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Preface
PREFACE
This thesis describes the MS/MS investigation of polyamine spider toxins and
related compounds. It consists of an introductory paragraph, which deals with the
collection of spider venom, and of four separate chapters describing our detailed
analytical investigations. Each chapter is independent from the others and has its
own numbering of the schemes, figures, substances, and references.
Chapter 1 describes the synthesis of a small library of naturally occurring
acylpentamines and the correlation of their HPLC-MS and -MS/MS behavior with
components found in the venom of the spider Agelenopsis aperta. This chapter is
published in Helv. Chim. Acta 2002, 85, 2827. Chapter 2 discusses the MS/MS
fragmentation mechanisms of acylpentamines and their 15N-labeled derivatives to
explain the origin of several unexpected fragment ions. This chapter is published in
J. Am. Soc. Mass Spectrom. 2004, 15, 1636. Chapter 3 presents the detection of linear free
polyamines and their N-hydroxylated, guanidylated, and acetylated derivatives by
HPLC-MS in the venom of the spiders Agelenopsis aperta, Hololena curta, and
Paracoelotes birulai. This chapter is published in Toxicon 2005, 46, 0000. Chapter 4,
finally describes the isolation, structure elucidation, MS/MS fragmentation behavior,
and synthesis of the two new spermidine alkaloids, Chisitine 1 and 2. This chapter is
published in Helv. Chim. Acta 2004, 87, 1411.
The synthetic parts to the several acylpolyamines used in Chapter 1 and 2 of this
thesis were contributed by Dr. N. Manov and are also parts of his Ph.D. thesis (2003).
They are included in this manuscript as a part of the published papers and to place
our MS/MS investigations into a proper context.
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SUMMARY
Polyamine-containing natural products are found in many animals and plants. For
instance, spider venoms — whereon we focused our research — are known to be a
rich source of acylpolyamine toxins. These biologically active compounds interact,
e.g., with ion channels in the mammalian central nervous system and are thus of
therapeutical interest for the study of brain disorders such as Parkinson’s and
Alzheimer’s diseases. The toxins are found in the spider venoms within complex
mixture of several types of compounds and they are available in trace amounts only.
Therefore, sophisticated and highly sensitive analytical methods are required to
detect and analyze these compounds. In the recent years, high-performance liquid
chromatography coupled with mass spectrometry (HPLC-MS) has found a wide
application in the detection of low abundant natural products, and particularly in the
investigation of acylpolyamines in spider venoms. In combination with tandem-mass
spectrometry (MS/MS or MSn), efficient structural elucidation of the analytes was
achieved.
To rely the structural elucidation of polyamine toxins on MS-methods alone,
however, the fragmentation behavior of the sample molecules has to be well
understood. To learn more about their behavior, the MS/MS data of structurally well
defined and chemically pure reference compounds have to be collected and studied.
For this purpose, synthesis of the toxins and model compounds is often necessary.
This thesis presents the structural elucidation of several polyamine containing
natural products found in spider venoms and in the leaves of a tree, based essentially
on HPLC-MS and -MS/MS experiments.
Chapter 1 discusses the results of our investigation of the venom of the spider
Agelenopsis aperta. We were able to detect some acylpentamine toxins postulated to be
contained in the venom in addition to those previously reported. To do so, we used a
library of twelve synthetically pure reference compounds prepared by solid-phase
synthesis. The library consisted of four linear pentamine isomers, each acylated with
three different head acyl groups. These synthetic compounds were compared with
respect to their chromatographic and MS/MS behavior with the components of the
natural toxin mixture. To investigate the chromatographic behavior, the synthetic
references were admixed to the natural venom, and the increase of the
chromatographic peaks was monitored (Figure 1). With such comparative studies, we
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confirmed the presence and structure assignments of seven known toxins, and we
were able to detect five new pentamine derivatives within the complex venom
mixture. The study of the MS/MS data of the several pure synthetic isomers revealed
a characteristic fragmentation pattern for the acylpentamines. The typical MS/MS for
each isomer is a particular consequence of the location of the ‘tetramethylene unit’
within the polyamine backbone, since the 1,4-diaminobutane moiety dominates the
fragmentation behavior of the compounds. Our findings allowed the characterization
of new polyamine derivatives without the need for their chemical synthesis.
Figure 1. Extracted ion chromatograms (EIC) of the ions at m/z 417 in natural venom of
A. aperta and— exemplarily — in spiked venom with synthetic IndAc4333.
Chapter 2 discusses the origin of a series of unexpected fragment ions that were found
in the MS/MS of the acylpentamines described in Chapter 1. The identity of these
ions is crucial since they could lead to misinterpretation of the fragmentation spectra
and consequently to incorrect structure assignments of the toxins. For this study,
three 15N-labeled isomers of IndAc3334 were prepared by solid-phase synthesis and
investigated by MS/MS. The three isomers were carrying the labeled N-atom at three
different positions within the polyamine backbone. The MS/MS of the labeled
compounds allowed, e.g., to identify the internal portion of the molecule highlighted
in IndAc3315N34 of Figure 2 to be contained in the unexpected signal 15N-b33.
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Figure 2. MS/MS spectra of the pentamine derivative IndAc3334 and its 15N-labeled analog
IndAc3315N34.
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Scheme 1. Sequential fragmentation mechanism of the pentamine derivative IndAc3315N34
during MS/MS.
Summary 4
From this observation, a sequential fragmentation mechanism (Scheme 1) as well as a
rearrangement/fragmentation mechanism were proposed for the decomposition of
acylpolyamines during MS/MS.
Chapter 3 presents the investigation of early HPLC-fractions of the venom of the
spiders Agelenopsis aperta, Hololena curta and Paracoelotes birulai containing linear
polyamines. This study was motivated by the assumption that linear polyamines are
the biosynthetic precursors of the parent acylpolyamines. Due to the absence of UV-
activity, the detection of the non-acylated polyamine compounds had to be based
solely on HPLC-MS and -MS/MS. As a result, we detected in addition to
underivatized compounds, thirteen new N-hydroxylated, guanidylated or acetylated
polyamines (Figure 3). Furthermore, Chapter 3 discusses a possible biosynthesis of
acylpolyamines in spider venoms.
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Figure 3. Structures of the linear hexamine derivatives detected in A. aperta, H. curta, and
P. birulai.
In Chapter 4, we describe the structural elucidation of two new trisubstituted
spermidine alkaloids, isolated from a methanolic extract of the leaves of the southern
Irian Jaya tree Chisocheton weinlandii. The two compounds, named Chisitine 1 and
Chisitine 2 (Figure 4), were characterized by NMR spectroscopy, HPLC-MS, and
HPLC-MSn.
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Figure 4. Structure of the spermidine alkaloids Chisitine 1 and 2 isolated from
C. weinlandii, and of a synthetic 18O-labeled Chisitine 2 isotopomer.
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Moreover, the structure elucidation of the chisitines was secured by synthesis of the
compounds and by their comparison with the natural products. Chapter 5 discusses
the MSn fragmentation scheme of Chisitine 2 based on H/D-exchange experiments
and the investigation of an 18O-labeled analog. The study will possibly allow the
detection of additional related polyamine alkaloids from plant material, due to their
characteristic MS/MS fragmentation behavior.

Zusammenfassung 7
ZUSAMMENFASSUNG
Naturprodukte, die Polyamine enthalten, werden bei zahlreichen Tier- und
Pflanzenarten gefunden. Zum Beispiel Spinnengifte   auf welche wir unsere
Forschungen fokussierten   sind bekannt als reichhaltige Quellen von
Acylpolyamin-Toxinen. Diese biologisch aktiven Substanzen beeinflussen z.B. Ionen-
Kanäle im zentralen Nervensystem von Säugetieren und sind deshalb wertvoll für
potenzielle therapeutische Zwecke im Zusammenhang mit Gehirnerkrankungen wie
der Parkinson- oder Alzheimer-Krankheit. Spinnengifte stellen eine komplexe
Mischung aus verschiedenen Typen von Verbindungen dar, wobei Polyamin-Toxine
nur einen kleinen Teil davon ausmachen. Aus diesem Grund sind hoch entwickelte
und empfindliche analytische Methoden nötig, um diese nur in kleinsten Mengen
vorhandenen Komponenten zu detektieren und zu analysieren. In den letzten Jahren
hat dazu die Hochleistungs-Flüssigkeitschromatographie gekoppelt mit
Massenspektrometrie (HPLC-MS) eine spezielle Bedeutung erhalten. Neben der
reinen Detektion von in spuren vorliegenden Substanzen erlaubt die Methode, in
Kombination mit der Tandem-Massenspektrometrie (MS/MS oder MSn) zusätzlich
die Strukturaufklärung der Probemoleküle.
Damit die Struktur von Polyamin-Toxinen alleine auf der Basis von MS-Methoden
bestimmt werden kann, muss das Fragmentierungsverhalten der untersuchten
Verbindungen gut verstanden sein. Um dieses Fragmentierungsverhalten verstehen
zu lernen, müssen die MS/MS-Daten der Naturprodukte analysiert und mit
Messdaten von bekannten und chemisch reinen Referenzverbindungen verglichen
werden. Zu diesem Zweck müssen oft spezifische Toxine oder Modellmoleküle
synthetisiert werden.
Diese Dissertation zeigt die Strukturaufklärung von verschiedenen Polyamin-
Naturprodukten auf, die in Spinnengiften oder in den Blättern eines Baumes
vorkommen. Die Untersuchungen stützen sich im wesentliche auf HPLC-MS und
-MS/MS Experimente.
In Kapitel 1 wird der Nachweis von Acylpolyaminen im Spinnengift von Agelenopsis
aperta aufgezeigt. Acylpolyamine wurden bereits früher im Gift von A. aperta
gefunden, einige davon konnten jedoch strukturell nicht eindeutig nachgewiesen
werden. Wir benötigten für unseren Nachweis zwölf synthetisch hergestellte, reine
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Verbindungen, die mit Festphasensynthese erhalten wurden. Die
chromatographischen und MS/MS-Eigenschaften der synthetischen Komponenten
wurden mit denjenigen der natürlichen Komponenten des Spinnengiftes verglichen.
Um das chromatographische Verhalten zu untersuchen, wurden die synthetischen
Verbindungen mit dem Spinnengift gemischt (Figur 1). Unsere Sammlung von
Polyaminderivate beinhaltete jeweils vier lineare Acylpentamin-Isomere, welche mit
je drei verschiedenen Acyl-Gruppen gekoppelt waren. Anhand der
Vergleichsmethode, die wir bei dieser Studie herangezogen haben, konnten wir die
Existenz der bereits bekannten sieben Verbindungen nachweisen und zusätzlich fünf
neue Acylpentaminderivate im komplexen Spinnengift bestimmen.
Figur 1. "Extracted ion chromatograms" (EIC) der Ionen m/z 417 in natürlichem und in
mit synthetischem IndAc4333 gemischtem Gift von A. aperta.
Die Untersuchung der verschiedenen synthetischen Isomere mittels MS/MS hat
gezeigt, dass die einzelnen Verbindungen ganz unterschiedliche, charakteristische
Fragmentierungsmuster zeigen. Die Charakteristik der MS/MS-Spektren der
einzelnen Isomere ist jeweils eine Konsequenz der Position der "Tetramethylen-
Einheit" in der Polyaminkette, weil diese 1,4-Diaminobutan-Einheit das
Fragmentierungsverhalten der Polyamine dominiert. Die Ergebnisse dieser
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Untersuchung erlauben es uns nun neue Polyaminderivate zu charakterisieren, ohne
sie synthetisieren zu müssen.
Kapitel 2 berichtet über die Herkunft unerwarteter Fragment-Ionen, die in den
MS/MS-Spektren der synthetischen Acylpentaminen (Kapitel 1) gefunden wurden.
Die Identifizierung dieser Ionen ist wichtig, da es in Unkenntnis ihrer
Entstehungsweise zu Fehlinterpretationen bei der Analyse von Fragmentierungs-
Spektren und somit zu falschen Strukturzuordnungen bei der Untersuchung von
Polamin-Toxine führen könnte. In dieser Studie wurden drei 15N-Isotopen-markierte
Isomere von IndAc3334 mittels Festphasensynthese hergestellt und mit Tandem-
Massenspektrometrie untersucht.
Figur 2. MS/MS-Spektren von Verbindung IndAc3334 und von 15N-Isotopenmarkierter
IndAc3315N34.
Das 15N-Isotop wurde an drei verschiedenen Stellen der Polyaminkette eingesetzt.
Die Interpretation der MS/MS-Spektren dieser Substanzen ermöglichten es uns zu
zeigen, dass ein vorher schwierig zu erklärendes Fragment-Ion aus dem internen Teil
der Polyaminkette von IndAc3315N 3 4  stammt (siehe Figur 2). Aus diesen
Beobachtungen wurden ein sequenzieller Fragmentierungs-Mechanismus (Schema 1)
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und ein Umlagerungs/Fragmentierungs-Mechanismus vorgeschlagen, welche die
Abspaltungen von Acylpolyaminen in MS/MS Experimenten erklären können.
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Schema 1. Sequenzieller MS/MS Fragmentierungs-Mechanismus für das Pentaminderivat
IndAc3315N34.
In Kapitel 3 wird die Detektion lineare Polyamine im Spinnengift von Agelenopsis
aperta, Hololena curta and Paracoelotes birulai aufgezeigt. Diese Studie wurde aufgrund
der Vermutung durchgeführt, dass lineare Polyamine die biosynthetischen Vorläufer
der entsprechenden Acylpolyamine sein könnten. Da die freien Polyamine keinen
Chromophor besitzen, ist der Nachweis solchen Komponenten auf reine HPLC-MS-
und -MS/MS-Daten zu beziehen. Neben unacylierten Verbindungen konnten
dreizehn neue N-hydroxylierte, guanidylierte oder acetylierte Polyamine gefunden
werden (Figur 3).
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Figur 3. Strukturen von linearen Hexaminderivaten, welche im Spinnengift von A. aperta,
H. curta, und P. birulai gefunden wurden.
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Des Weiteren berichtet Kapitel 3 über unsere Vorstellungen zum Biosynthese von
Acylpolyaminen in Spinnengiften.
In Kapitel 4 wird die Strukturaufklärung von zwei neuen tri-substituierten
Spermidin-Alkaloiden beschrieben, die in einem Blätterextrakt des südlichen Irian
Jaya Baumes Chisocheton weinlandi gefunden wurden. Die zwei Verbindungen,
genannt Chisitin 1 und Chisitin 2 (Figur 4), wurden mit NMR-Spektroskopie, HPLC-
MS, und -MSn charakterisiert. Zudem wurden beide Verbindungen synthetisiert und
die analytischen Daten der synthetischen Proben mit denjenigen der Naturprodukte
verglichen. Kapitel 4 berichtet zudem über den Fragmentierungsweg von Chisitin 2
im MS/MS, welcher auf der Basis von H/D-Austausch-Experimenten und der
Untersuchung eines 18O-markierten synthetischen Analogons abgeleitet wurde. Die
Resultate können für die Strukturaufklärung von weiteren ähnlichen Polyamin-
Alkaloiden aus Pflanzen herangezogen werden.
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Figur 4. Struktur der Spermidin-Alkaloide Chisitin 1 und 2 aus C. weinlandii und des
synthetisch hergestellten 18O-markierten Chisitins 2.
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COLLECTION OF SPIDER VENOMS
Spiders are an incredibly diverse yet largely unexplored source for the discovery of
novel and useful venom toxins with unique properties. To promote their exploration,
several farms got specialized in breeding of spiders as well as of other arthropods
such as scorpions . The venoms used for our investigations were obtained from
Fauna Laboratories, Ltd.1, in Almaty (Kazakhstan). In general, juvenile spiders are
grown up at very high densities in plastic cups during one or two instars. Once
adult, the spiders are separated and individually housed in plastic cups where they
develop well if they obtain sufficient prey and are kept under suitable external
conditions. The spiders in question   Agelenopsis aperta, Hololena curta, and
Paracoelotes birulai  are held optimally at 27° and 60% relative humidity, they are
fed with housefly maggots or wax worm larvae and crickets.
Among the several methods reported to collect venom from spiders, electro-
stimulated “milking” is the preferred one. There are several reasons for this: (1) it is
assumed that milked venoms, as compared to venoms obtained by gland dissection
and extraction, are more similar to the actual venoms spiders use to paralyze or kill
their prey; (2) the venoms should be less contaminated by extraneous material like
residues of cell debris and digestive fluids, containing proteases and enzymes that
may lead to degradation of the toxins present in the venoms; and (3) the spiders have
not to be killed and can repetitively be used for milking in periods ranging in general
from one to three weeks.
To obtain the venoms for our investigations, the respective spiders (Agelenopsis
aperta, Hololena curta, and Paracoelotes birulai) were first anesthetized by exposure to
chloroform or carbon dioxide for a couple of minutes. Once motionless, the spiders
were brought with modified tweezers under a dissecting microscope with typically
20 times magnification. The first prong of the tweezers, covered with a saline-soaked
foam pad, was placed against the sternum, the second insulated one against the
carapace just behind the eyes of the arachnidae. By holding the spiders upside down
(ventrum facing the operator), the chelicerae and fangs were rinsed with a jet of
water using a syringe to remove any residual digestive fluids (Figure 1). The
                                                 
1 Adress: Dr. Andrey Fedorov, Fauna Laboratories, Ltd., Academgorodok, Institute of Zoology,
480060 Almaty, Kazakhstan. Internet homepage: http://www.faunalabs.com.
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chelicerae and fangs were then meticulously examined for debris or moisture and, if
needed, rinsed with water again.
Figure 1. Rinsing of the chelicerae and fangs of the spider Paracoelotes birulai to remove
any residual digestive fluid.
After this cleaning procedure, the chelicerae of the spiders were leant against an
electrically conducting pin and "rejection" of the venom is stimulated by applying
successive low current electrical shocks. In most cases, a simple foot-switch
controlled stimulator, delivering a 60 Hz alternating current of 50–150 mA was used.
The expelled venom was directly collected from the fangs in a capillary glass tube
(Figure 2).
Figure 2. Microscope view of the venom collected from the spider Paracoelotes birulai.
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The process of milking was observed directly under the microscope to ensure that
the capillary comes in contact solely with the chelicerae and fangs. Typically, the
investigated spiders yielded approximately from 0.2 to 0.5 µl of venom per milking.
After the milking, the spiders were placed back into their habitats and the animals
recovered within a few minutes. In a milking session, the milking operation was
usually performed successively with eight to sixteen individuals of the same species
at intervals of about 20 seconds to one minute, collecting the venom in a single
capillary tube. The combined venom (2–10 µl) was then aspirated from the glass
capillary into a vial held at –20°. The fluid was lyophilized and produced a colorless
powder (1–3 mg) which was stored at –80° to avoid decomposition. To obtain larger
amounts of venom, the spider colonies were repetitively milked in periods ranging in
general from one to three weeks.
The amount of venoms to be investigated at our disposal are summarized in the
following table:
Spider Family Volume [µl] Amount [mg]
Agelenopsis aperta Agelenidae 500 100
Hololena curta Agelenidae 50 10
Paracoelotes birulai Amaurobiidae 50 10
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CHAPTER 1
Solid-Phase Synthesis of Polyamine Spider Toxins from the Center and
Correlation with the Natural Products by HPLC-MS/MS1
Abstract
A recently developed new and divergent approach for the solid-phase synthesis of
polyamines and polyamine derivatives was extended to the preparation of linear
pentamines, and it was applied to the synthesis of three quartets of isomeric
polyamine spider toxins. The twelve synthetic acylpolyamines were investigated by
HPLC-UV(DAD)-MS and HPLC-UV(DAD)-MS/MS and compared with the natural
products in the complex mixture of the venom of Agelenopsis aperta. The comparative
investigation supported the structures and assignments of seven previously found
toxins and allowed the identification of an additional five polyamine derivatives in
the natural sample. The MS/MS study of the isomerically pure polyamine
derivatives revealed furthermore a characteristic pattern for the fragmentation of
these compounds, which can possibly be used as an evidence in the trace-analysis of
other polyamine derivatives.
Introduction
Linear polyamines like putrescine, spermidine, and spermine, but also more
uncommon representatives, are widely distributed throughout the animal and plant
kingdoms. They occur either free in protonated form or as conjugates connected to
other biomolecules. Since they exhibit in either form a variety of biological activities
[1-4], it is not surprising that polyamines as well as their analogs and derivatives are
considered as therapeutic leads for the treatment of a variety of diseases.
Unfortunately, natural polyamine derivatives arise often in small amounts and
frequently within complex mixtures only. This makes their use in systematic
biological investigations unviable. To study the detailed function and action of
polyamine compounds, it is, thus, of particular interest not only to have access to a
broad spectrum of different polyamine derivatives, preferably also to new substrates
                                                 
1 N. Manov, M. Tzouros, S. Chesnov, L. Bigler, S. Bienz, Helv. Chim. Acta 2002, 85, 2827.
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from natural sources, but also to sufficient amounts of pure samples. Highly
sophisticated analytical methods to find new lead structures in nature combined
with synthetic protocols to provide the respective compounds in ample amounts are,
therefore, the optimal team players to support biological investigations related to the
polyamines.
Recently, we have been increasingly engaged in the analysis and characterization of
polyamine toxins from spiders, in particular from Agelenopsis aperta [5] and from
Paracoelotes birulai [6], by on-line coupled high-performance liquid chromatography
and atmospheric-pressure chemical ionization mass spectrometry (HPLC-UV(DAD)-
APCI-MS and MS/MS). In the venom of A. aperta, e.g., as many as 33 acylpolyamines
with 11 different molecular masses were detected by this method. Most of the
structures were securely elucidated by MS/MS, but some evaded explicit
determination.
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Figure 1. Typification, structures, and names of the acylpentamines found partially in the
venom of the spider A. aperta.
It was found that the MS/MS analysis of several venom ‘components’ (selected by
their retention times in HPLC and their ion masses) do not conform completely to the
fragmentation patterns that would be expected for ‘pure sample ions’. Such
irregularities have been interpreted as the manifestation of overlapping spectra
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deriving from co-eluting compounds contained in the natural toxin mixture. For
IndAc pentamines it was, e.g., cautiously concluded that IndAc3334 (AG 416a,
compound of type A) and IndAc3343 (AG 416, compound of type B) are such co-
eluting components of the venom (Figure 1). The isomeric derivative IndAc4333 (AG
416b, compound of type D), with a different chromatographic behavior, was also
uncovered in the venom, while the remaining isomer IndAc3433 (compound of type
C), was not identified. While the structural elucidations for IndAc3334 and IndAc4333
appear quite conclusive, the evidence for the constitution of IndAc3343 (AG 416) is
rather weak. The assignment is based more on literature precedence — the
compound was considered one of the major constituents of the venom of A. aperta [7]
and of H. curta [8] — than on spectroscopic evidence. As a matter of fact, the MS/MS
response at m/z 343, taken as the diagnostic signal for a fragment deriving from
IndAc3343, could likewise be attributed to a fragment of equal mass deriving from
IndAc3433 (Figure 2). Additionally, the signal at m/z 115, which was regarded as
characteristic for the PA33 terminus in IndAc4333 (AG 416b), would indicate the
presence of a structure also possessing a terminal PA33 unit. Such a compound
would be IndAc3433 rather than IndAc3343.
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Figure 2. Proposed indicative fragment of IndAc3343 (AG 416) and fragments potentially
derived from IndAc3433.
Since we have only marginal knowledge of the fragmentation behavior of the
acylpolyamines, it cannot be excluded that the ‘unusual’ signals in the MS/MS
spectra are not due to co-eluting isomeric compounds. They could have also been
generated by unexpected fragmentation reactions occurring with the structurally
secured IndAc3334. To unambiguously establish (or disprove) the presence and
structures of the proposed indole-acetamides within the natural venom — eventually
to find the remaining isomer IndAc3433, too — the respective compounds were
Chapter 1 20
synthesized, and they were analyzed separately and in comparison with the natural
compounds by HPLC-UV(DAD)-MS and -MS/MS . Additionally, the analogous
substrates with the 4-hydroxybenzoic (4-OH-Bz) and the 2,5-dihydroxybenzoic (2,5-
(OH)2-Bz) acid head portions were prepared as well. The corresponding isomers of
type A and D were found in the venom cocktail of A. aperta, too, but the isomeric
structures of type B and C have not been identified so far. For the synthesis of the
twelve target structures we had a powerful and efficient tool at hand, namely our
recently developed new solid-phase methodology [9]. This methodology allows the
construction of polyazaalkanes from their centers and the specific and separate
modification of the linear polyamines at either end.
Results
Synthesis of the Polyamine Toxins
As already described previously, Merrifield resin (200–400 mesh, 1% divinylbenzene,
0.9 mmol/g loading capacity) was converted to resin 1 by its coupling with mono-
Boc-protected 1,3-diamine followed by alkylation of the benzylic amine with 1,3-
dibromopropane [9]. Elongation of the polyamine backbone was subsequently
effected by treatment of resin 1 with N,N’-dibenzylpropane-1,3-diamine or N,N’-
dibenzylbutane-1,4-diamine in 1-methyl-2-pyrrolidone (NMP) in presence of EtN(i-
Pr)2 and DIEA (Scheme 1). The resultant tetraminic resins 2 and 3 were further
extended by alkylation of the terminal secondary amines with N - ( 4 -
bromobutyl)phthalimide or with  N-(3-bromopropyl)phthalimide, respectively. This
afforded the orthogonally protected resin-bound pentamine core structures 4 and 5,
respectively. The yields achieved so far amounted to ca. 30%, which was tested by
removal of the polyamines from the resins and quantification of the liberated
products.
To access the small library of selected target molecules, the protective groups of the
terminal amino functions were cleaved off specifically and replaced with the
appropriate acid moieties. Thus, resins 4 and 5 were treated either with TFA or with
N2H4·H2O to selectively remove the Boc or phthaloyl groups, respectively. Each of
the product resins 6–9 was subsequently acylated with each of the three protected
acids — N-(tert-butyldimethylsilyl)-1H-indole-3-acetic acid (TBSIndAcOH), 4-
acetoxybenzoic acid (4-(AcO)-Bz), and 2,5-diacetoxybenzoic acid (2,5-(AcO)2-Bz) —
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Scheme 1. Synthetic route to the acylpentamines of type A–D.
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by their mutual treatment with diisopropyl carbodiimide (DIC). Reaction of the
resins 10–21 with 1-chloroethyl chloroformate (ACE-Cl) followed by MeOH [10] or
MeOH/N2H2·H2O (for the N-phthaloyl derivatives 10–15) provided the desired,
properly derivatized twelve pentamine derivatives, devoid of all protective groups.
The products were either purified by preparative HPLC or simply by rinsing with
MeOH and were finally collected as their HCl or TFA salts in 10–30% overall yields.
Alternatively to the procedure described above, the phthaloyl group of the resins
10–15 can be cleaved off the polyamine prior to its release from the polymer support.
Without adding N2H2·H2O to the methanolic solution during the cleavage procedure,
the phthaloyl group can also be retained as a protective group in the final product.
During the preparation of the indole-acetamides, we encountered one noteworthy
problem. It turned out that the choice of the acid derivative to be coupled with the
polyamine backbone is not trivial. Indole-3-acetic acid itself as well as its N-Boc-
protected derivative proved not to be the appropriate reagents. Upon cleavage of the
corresponding final acylpolyamines from the resin, complete decomposition of the
products was observed, possibly due to oxidation. Less decomposition was noticed
when more stable protective groups than Boc were used at the indole N-atom. At
least, satisfactory yields of cleavage products were obtained with N-Bn-, N-Ts-, and
N-TBDMS-protected compounds (17, 13, and 11%, respectively, for products
deriving from resin 8). Since the hydrogenolytic removal of the Bn group was
accompanied with partial reduction of the indole moiety, and, also, the reductive
cleavage of the Ts group by the action of MeOH/Mg was not quantitative in yield
(80%), the use of the TBDMS-protected indole-acetic acid in the acylation step was
finally found to be appropriate.
Correlation of the Synthetic Samples with the Natural Toxins Within the Venom
Chromatographic Behavior—Several synthetic polyamine derivatives were analyzed
individually or as defined mixtures with each other and with the natural venom by
HPLC-UV(DAD)-MS and HPLC-UV(DAD)-MS/MS under the standard conditions
used previously [5]. Figure 3 shows representatively the extracted-ion
chromatograms (EIC) of the quasi-molecular ions at m/z 417 for the natural venom
and for mixtures of the natural venom with the four synthetic IndAc-polyamines.
It is easily recognized from these chromatograms that the three isomeric compounds
IndAc3334, IndAc3343, and IndAc3433 all co-elute with the first fraction (tR = 26.0
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min) of the natural venom. The remaining isomer, IndAc4333, co-elutes with the
second fraction of the native toxin mixture (tR = 27.5 min). Similar pictures as with
the IndAc-polyamines were gained with the other two groups of acylpolyamines
(EICs of ions m/z 396 and 380 for the 4-OH-Bz and the 2,5-(OH)2-Bz derivatives,
respectively). Also for these compounds, the three isomers of types A–C (Acyl3334,
Acyl3343, and Acyl3433) all co-elute with the first fractions of the natural venom
components, whereas the remaining isomers of type D (Acyl4333) co-elute with the
respective second fraction.
MS/MS-Fragmentation—Due to the co-elution of the several compounds in HPLC, the
single-ion detected chromatographic results do not allow a definite structure
correlation for all the toxins contained in the natural venom. Additional information,
however, can be gained from the HPLC-MS/MS experiments. The respective spectra
of the four isomeric IndAc-pentamines (IndAc3334, IndAc3343, IndAc3433, and
IndAc4333) and of two chromatographic fractions of the natural venom are shown in
Figure 4. The complete set of results obtained from the investigation of all synthetic
polyamine derivatives and the corresponding natural toxin fractions are given in the
Experimental Part.
It is readily realized from the illustrations in Figure 4 that the collision induced
dissociation (CID) spectra of the quasi-molecular ions of the several isomerically
pure sample compounds lead to distinctively different peak patterns in the spectra.
However, most of the signals (with respect to the m/z values) are shared by at least
two of the four compounds. Nevertheless, characterization of the components of the
natural venom by correlation with the synthetic compounds should be viable
because of the distinctively different relative intensities of the signals manifested in
the separate spectra. In fact, spectrum f) of the second HPLC fraction of the biological
sample matches well — except for the two signals at m/z 112 and 215 — with
spectrum e) of IndAc4333. This corroborates the earlier structure assignment for
IndAc4333, which was recognized as the compound eluting at this position. Spectrum
d) of the first HPLC fraction, on the other hand, corresponds only largely to one of
the remaining spectra, namely to spectrum a) of IndAc3334.
The differences in the relative peak intensities and the additional ion responses
found in the spectrum of the natural probe, however, are distinctive enough to
deduce that IndAc3334 cannot be the sole component detected in the venom fraction.
Analysis of the corresponding spectra of the 4-OH-Bz and 2,5-(OH)2-Bz polyamines
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revealed similar insights: the MS/MS of the second fractions of the natural toxin
mixture correspond nicely to the Acyl4333 derivatives and the spectra of the first
fraction correlates largely, but not completely, to the Acyl3334 compounds. The
question arose, thus, whether it is possible to characterize one or the other of the
remaining acylpolyamines as the additional constituents of the natural probe.
Scrutiny of the spectral data of the whole collection of synthetic compounds showed
that only a few MS/MS signals are unique and thus characteristic for the individual
isomeric acylpolyamines. Only these signals can be regarded as diagnostic for the
different polyamine substructures and their attachments to the acyl groups. Of
particular interest are the characteristic signals deriving from the compounds of type
A–C within the three classes of isomers, because these substances co-elute in the
HPLC. Table 1 compiles these diagnostic signals obtained from the corresponding
quasi-molecular ions m/z 417, 380, and 396. Additionally, some other potentially
characteristic peaks and the CID patterns of the respective first eluting fractions of
the natural venom are also included in Table 1. The data in Table 1 shows clearly that
the spectra of the first-eluting venom fractions of all three classes of acylpolyamines
are each superimposable on the spectra of all three respective acylpentamines of type
A–C.
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The major components of the natural toxin mixtures are, in all cases, recognized as
the Acyl3334  derivatives, as already realized above for IndAc3334. All four
characteristic peaks for the fragments of type a, b, c, and c–H2O of these isomers are
found in high abundance in the three spectra of the natural compound fractions. The
presence of the Acyl3343 derivatives in the natural mixture is manifested with the
two diagnostic fragments of type c and c–H2O, which were recorded with substantial
intensities in all three spectra of the natural venom fractions. For the Acyl3433
derivatives, only one single characteristic signal, corresponding to a fragment of type
e, can be extracted from the data of the isomerically pure samples, and the respective
responses for fragment e are detected also in the spectra of the natural venom
fractions. While the abundance of fragment e  for IndAc3433 is substantial in the
spectrum of the venom (21 rel.%), the intensities for the related fragments of 4-OH-
Bz3433 and 2,5-(OH)2-Bz3433 are rather low (3 rel.% each). Nevertheless, these
signals are regarded as significant enough to conclude that all three Acyl3433
derivatives are constituents of the natural spider venom.
Discussion
Our comparative HPLC-MS/MS investigation of synthetic polyamine derivatives
and of natural polyamine fractions of A. aperta largely supports the results and
deductions published earlier [5]. It unambiguously confirms all the previously
proposed compounds to be contained in the natural venom. It furthermore
establishes the occurence of five additional polyamine toxins that have not been
identified so far. We have shown that the venom contains, for each of the three
aromatic head groups, all four possible isomeric acylpolyamines related to the parent
pentamines PA3334 and PA3343, i.e., all compounds of type A–D.
The presence of all these isomeric acylpentamines is strongly indicative for the
biosynthetic pathway of the compounds in spiders. Even though the free polyamines
themselves were not yet reported in the venom of A. aperta, we assume that they
represent the biosynthetic precursors of the several toxins. We propose that the final
toxin cocktail of the spiders is derived from ‘statistical’ acylation of the two parent
pentamines at either end of the molecules.
Besides the identification of the twelve synthetic acylpentamines as constituents of
the venom of A. aperta, our MS/MS study exposed also some interesting
spectrometric peculiarities. First, the spectra of the synthetic IndAc3343 and
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IndAc3433 revealed that the signal at m/z 343 for fragment c is, in fact, indicative for
the former compound. As outlined earlier, the formation of a fragment with m/z 343
could principally also be due to the decomposition of IndAc3433. However, the
corresponding fragmentation of the latter is much less pronounced. This is possible
because the reaction, in contrast to the reaction of IndAc3343, cannot proceed via a
five-membered cyclic intermediate. The respective proposed fragmentation reactions
are outlined in Scheme 2. The same effect as with IndAc3343 and IndAc3433 was
observed for the two other pairs of acylpolyamines with the 4-OH-Bz and the 2,5-
(OH)2-Bz groups (fragments c at m/z 306 and 325, respectively).
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Scheme 2. Proposed fragmentation reactions leading to the formation of fragment ions at
m/z 343 from IndAc3343 and IndAc3433.
It is evidently also not restricted to the formation of fragments of type c: all
fragmentations proceeding analogously via five-membered cyclic transition states are
clearly favored reactions. This is demonstrated, for instance, with the abundant
signals for fragments a observed for the Acyl3334 derivatives. They are due to the
loss of NH3 from the respective quasi-molecular ions by intramolecular nucleophilic
substitutions (sNi) via five-membered transition states. The analogous reaction of the
isomeric acylpolyamines would all have to proceed via four-membered transition
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structures and are, thus, less pronounced; in fact, the respective signals are not
observed at all.
Another peculiarity in the fragmentation behavior of the acylpolyamines became
evident. We would have expected, as mentioned earlier, to find fragment f at m/z 115
to be decisive for the Acyl3433 derivatives (Scheme 3). The fragment, which was
attributed to structure A, would be released from a polyamine with a terminal PA33
unit. Fragment f at m/z 115, however, was also observed with high abundance in the
MS/MS of the Acyl3334 derivatives lacking the PA33 termini. It was not found, or
was found only with negligible intensity, however, in the Acyl3343 derivatives
possessing an inverted PA34 unit at the end. The formation of the fragment with m/z
115 from Acyl3334 derivatives can be explained by two processes, which involve a
ZIP-reaction (Scheme 3) [11]. The quasi-molecular ions could lead either by a cascade
of sNi reactions (transaminations) or transamidation processes — all proceeding via
six-membered cyclic transition states — to intermediary structures B or C . These
intermediates are both prone to loose fragment A corresponding to the observed
signal. The analogous ZIP-reactions with the Acyl3343 derivatives are less
advantageous since, they would involve at one stage a group transfer via an
unfavorable seven-membered cyclic transition state [12-14]. Acid-catalyzed
transamidation during MS analysis was already found earlier [15]; for the
transamination reaction, no literature precedence is available. The latter reaction was
nevertheless considered because relevant and expected fragmentation of the
transamidation products was not observed. For instance, no loss of PA33 from ion C
was detected (m/z 286, 249, and 265, respectively, for the three Acyl3334).
Conclusion
Our study has shown that the conclusive and final analysis of trace components
within complex mixtures of polyamine spider toxins needs synthetic reference
samples of known structures. With such compounds at hand, we were not only able
to confirm seven proposed structures found previously in the venom of A. aperta but
also to detect five additional acylpolyamines, completing the set of isomeric
constituents contained in the natural sample. The solid-phase synthesis of the
polyamine derivatives proved to be a viable way to rapidly prepare the small library
of spider toxins, and we are confident that this strategy can be extended for the
preparation of more complex molecules as well.
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Experimental Part
1 . General. Unless otherwise stated, starting materials were obtained from
commercial suppliers and were used without further purification. Lyophilized
Agelenopsis aperta venom was purchased from Spider Pharm. Inc., Yarnell, AZ, U.S.A.
and was stored at –80°. As the solid support, Merrifield peptide resin 200–400 mesh,
1% divinylbenzene, loading 0.9 mmol/g from Advanced ChemTech was used.
Instrumentation for the solid phase reactions: PLS 4×6 and PLS 1×6 Organic
Synthesizers. IR spectra: as KBr presslings; Perkin-Elmer IR ‘Spectrum One’ and Perkin-
Elmer 781; in cm–1. 1H-NMR spectra: D2O or CDCl3; Bruker AC-300 (300 MHz); δ in
ppm rel. to TSP (δ 0.00) or CHCl3 (δ 7.26), J in Hz. 13C NMR spectra: D2O or CDCl3;
Bruker ARX-300 (75.5 MHz); δ  in ppm rel. to TSP (δ  1.7) or CDCl3 (δ  77.0);
multiplicities from DEPT-135 and DEPT-90 experiments. HPLC-UV(DAD)-MS and
HPLC-UV(DAD)-MS/MS: see detailed description under paragraph 7. Preparative
chromatographic conditions (HPLC): columns Kromasil KR100–10C18 (4.6 × 250 mm)
and Kromasil KR100–10C18 (50.8 × 250 mm); H2O was purified with a Milli-QRG
apparatus. Confirmation of structures and purities of the final polyamine derivatives
are provided by their 1H-NMR spectra and by their HPLC-MS analysis. Elemental
analyses and HR-MS is not appropriate for polyamine derivatives since the
compounds arise, as free bases, as waxy or glassy solids, from which the last solvent
molecules can hardly be removed. The HCl salts are rather hygroscopic, and the
uptake of H2O falsifies the elemental analyses. The compounds are not stable enough
to survive distillation and show heavy fragmentation in EI-MS. HR-MS on the
molecular ions is thus not possible, and HR-MS on fragment ions are not informative
enough to establish the overall structures.
2. Construction of the Polyamine Backbones on the Resin. 2.1. Elongation of Resin 1 with
N,N’-Dibenzylpropane-1,3-diamine (→ Resin 2). Resin 1 (4.1 mmol [9]) was swelled in 1-
methylpyrrolidin-2-one (NMP; 30 ml). N,N’-Dibenzylpropane-1,3-diamine (6.25 g,
24.6 mmol [16]) and EtN(i-Pr)2 (DIEA; 7.02 ml, 41 mmol) were added. After agitation
for 24 h at 50°, resin 2 was filtered off, washed with NMP and CH2Cl2, and dried in
vacuo.
2.2. Elongation of Resin 1 with N,N’-Dibenzylbutane-1,4-diamine (→ Resin 3). Resin 1 (4.1
mmol [9]) was swelled in NMP (30 ml), and N,N’-dibenzylbutane-1,4-diamine (6.59
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g, 24.6 mmol) and DIEA (7.02 ml, 41 mmol) were added. After agitation for 24 h at
50°, resin 3 was filtered off, washed with NMP and CH2Cl2, and dried in vacuo.
2.3. Alkylation of Resin 2 with N-(4-Bromobutyl)phthalimide (→  Resin 4). Resin 2 (4.1
mmol) was suspended in NMP (30 ml). N-(4-Bromobutyl)phthalimide (5.784 g, 20.5
mmol) and DIEA (7.02 ml, 41 mmol) were added, and the mixture was agitated for 26
h at 50°. Resin 4 was filtered off, washed with NMP, CH2Cl2 and MeOH, and dried in
vacuo. IR: 3426w, 1772w, 1714s.
2.4. Alkylation of Resin 3 with N-(3-Bromopropyl)phthalimide (→ Resin 5). Resin 3 (4.1
mmol) was suspended in NMP (30 ml). N-(3-Bromopropyl)phthalimide (5.494 g, 20.5
mmol) and DIEA (7.02 ml, 41 mmol) were added and the mixture was agitated for 26
h at 50°. Resin 5 was filtered off, washed with NMP, CH2Cl2 and MeOH, and dried in
vacuo. IR: 3427w, 1772m, 1714s.
3. Deprotection of the Terminal Amino Groups of the Resins. 3.1. Removal of the Boc Group
from Resin 4 (→ Resin 6). To resin 4 (1.64 mmol), swelled in CH2Cl2 (16 ml) was added
CF3COOH (TFA; 4.0 ml, 52 mmol). After agitation for 15 h at 23°, resin 6 was filtered
off, washed with CH2Cl2, CH2Cl2/DIEA 3:1, NMP, and CH2Cl2, and dried in vacuo at
50°. IR: 3384w, 1771w, 1714s.
3.2. Removal of the Boc Group from Resin 5 (→ Resin 7). To resin 5 (1.64 mmol), swelled
in CH2Cl2 (16 ml) was added TFA (4.0 ml, 52 mmol). After agitation for 15 h at 23°,
resin 7 was filtered off, washed with CH2Cl2, CH2Cl2/DIEA 3:1, NMP, and CH2Cl2,
and dried in vacuo at 50°. IR: 3420w, 1771w, 1714s.
3.3. Removal of the Phthaloyl Group from Resin 4 (→ Resin 8). Resin 4 (1.64 mmol) was
swelled in NMP (15 ml), and the mixture, after addition of N2H4⋅H2O (6.0 ml, 0.123
mol), was agitated for 3 h at 80°. Resin 8 was filtered off, washed with NMP, dioxane,
dioxane/H2O 1:1, dioxane, and CH2Cl2, and dried in vacuo at 50°. IR: 3426w, 1714s.
3.4. Removal of the Phthaloyl Group from Resin 5 (→ Resin 9). Resin 5 (1.64 mmol) was
swelled in NMP (15 ml) and the mixture, after addition of N2H4⋅H2O (6.0 ml, 0.123
mol), was agitated for 3 h at 80°. Resin 9 was filtered off, washed with NMP, dioxane,
dioxane/H2O 1:1, dioxane, and CH2Cl2, and dried in vacuo at 50°. IR: 3427w, 1714s.
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4. Acylation of the Resins. 4.1. General Procedure (GP 4.1). The resin (1.64 mmol) was
swelled in NMP/CH2Cl2 1:2 (15 ml). The appropriate carboxylic acid (16.4 mmol)
and N,N’-diisopropylcarbodiimide (1.27 ml, 8.2 mmol) were added, and the mixture
was agitated for 30 h at 23°. The product resin was filtered off, washed successively
with CH2Cl2, NMP, NMP/DIEA 10:1, NMP, and CH2Cl2, and was dried in vacuo at
50°. The Kaiser test [17] was performed to prove the absence of primary amino
groups.
4.2. Acylation of Resin 6 with TBSIndAcOH (→ Resin 10). Resin 6 was acylated with 2-
{1-[(tert-butyl)dimethylsilyl]-1H-indole-3}-acetic acid according to GP 4.1 to give
resin 10. IR: 3420m, 1770w, 1710s, 1665s.
4.3. Acylation of Resin 6 with 4-(AcO)-Bz (→ Resin 11). Resin 6 was acylated with 4-
acetoxybenzoic acid according to GP 4.1 to give resin 11. IR: 3420m, 1760m, 1715s,
1660m.
4.4. Acylation of Resin 6 with 2,5-(AcO)2-Bz (→ Resin 12). Resin 6 was acylated with 2,5-
diacetoxybenzoic acid according to GP 4.1 to give resin 12. IR: 3420w, 1765s, 1710m,
1665m.
4.5. Acylation of Resin 7 with TBSIndAcOH (→ Resin 13). Resin 7 was acylated with 2-
{1-[(tert-butyl)dimethylsilyl]-1H-indole-3}-acetic acid according to GP 4.1 to give
resin 13. IR: 3420w, 1775w, 1715s, 1680s.
4.6. Acylation of Resin 7 with 4-(AcO)-Bz (→ Resin 14). Resin 7 was acylated with 4-
acetoxybenzoic acid according to GP 4.1 to give resin 14. IR: 3420m, 1760m, 1715s,
1660m.
4.7. Acylation of Resin 7 with 2,5-(AcO)2-Bz (→ Resin 15). Resin 7 was acylated with 2,5-
diacetoxybenzoic acid according to GP 4.1 to give resin 15. IR: 3420w, 1765s, 1710m,
1665m.
4.8. Acylation of Resin 8 with TBSIndAcOH (→ Resin 16). Resin 8 was acylated with 2-
{1-[(tert-butyl)dimethylsilyl]-1H-indole-3-}acetic acid according to GP 4.1 to give
resin 16. IR: 3420w, 1710s, 1690s.
4.9. Acylation of Resin 8 with 4-(AcO)-Bz (→ Resin 17). Resin 8 was acylated with 4-
acetoxybenzoic acid according to GP 4.1 to give resin 17. IR: 3425w, 1760m, 1714s,
1663m.
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4.10. Acylation of Resin 8 with 2,5-(AcO)2-Bz (→ Resin 18). Resin 8 was acylated with
2,5-diacetoxybenzoic acid according to GP 4.1 to give resin 18. IR: 3420w, 1765m,
1715s, 1650m.
4.11. Acylation of Resin 9 with TBSIndAcOH (→ Resin 19). Resin 9 was acylated with 2-
{1-[(tert-butyl)dimethylsilyl]-1H-indole-3}-acetic acid according to GP 4.1 to give
resin 13. IR: 3420w, 1710s, 1690s.
4.12. Acylation of Resin 9 with 4-(AcO)-Bz (→ Resin 20). Resin 9 was acylated with 4-
acetoxybenzoic acid according to GP 4.1 to give resin 20. IR: 3425m, 1760m, 1715s,
1640m.
4.13. Acylation of Resin 9 with 2,5-(AcO)2-Bz (→ Resin 21). Resin 9 was acylated with
2,5-diacetoxybenzoic acid according to GP 4.1 to give resin 21. IR: 3420w, 1765m,
1715s, 1650m.
5. Cleavage of the Polyamine Derivatives from the Resins. 5.1. General Procedure (GP 5.1).
The resin (1.64 mmol) was swelled in 1,2-dichloroethane (15 ml) and 1-chloroethyl
chloroformate (ACE-Cl; 3.57 ml, 32.8 mmol) was added. After agitation for 3 h at 23°,
the product resin was filtered off and washed with CH2Cl2. The org. solns. were
combined and evaporated to dryness. The residues were dissolved in MeOH, and the
resulting soln. was refluxed for 3 h. For resins 10–15 (Phth-protected compounds),
N2H2·H2O (2.0 ml, 41 mmol) were added, and refluxing was continued for an
additional 2 h. The solvent was removed, and the solid residue, after washing of the
residue with MeOH, was collected. This provided the corresponding polyamine
derivative as the 4 HCl salt. Where appropriate, purification was followed by HPLC.
5.2. N-(16-Amino-4,8,12-triazahexadecyl)-1H-indole-3-acetamide (IndAc3334, AG 416a).
Treatment of 10 (1.55 mmol) according to GP 5.1 afforded IndAc3334·4 HCl (115 mg,
0.20 mmol; overall 13% with respect to 1) after purification by HPLC (solvent A:
0.05% HCl in MeOH; solvent B: 0.05% HCl in H2O; 25% A; λ = 254 nm; flow rate 20
ml min–1; the product was collected at 18.2–20.8 min). IR: 3380s, 3320m, 2950s, 2750s,
2520m, 2405m, 1650s, 1610w, 1535m, 1455m, 1050w, 780w, 740m. 1H-NMR (D2O):
7.68–7.53 (m , 2 arom. H); 7.38–7.15 (m, 3 arom. H); 3.77 (s, ArCH2); 3.35–3.00 (m, 12
H); 2.98–2.82 (m, 4 H); 2.22–1.94 (m, 4 H); 1.91–1.70 (m, 6 H). 13C-NMR (D2O): 180.5 (s,
CO); 140.8, 131.2 (2s, 2 arom. C); 129.7, 126.7, 124.1, 122.8, 116.6 (5d, 5 arom. C); 112.2
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(s, 1 arom. C); 51.6, 49.6, 49.17, 49.16, 49.1, 48.9, 43.4, 40.5, 37.0, 30.1, 28.4, 27.3, 27.2,
27.1 (14t). MS see paragraph 7.
5.3. N-(16-Amino-4,8,12-triazahexadecyl)-4-hydroxybenzamide (4-OH-Bz3334,  AG 379).
Treatment of 11 (1.62 mmol) according to GP 5.1 afforded 4-OH-Bz3334·4 HCl (250
mg, 0.48 mmol; overall 30% with respect to 1) after purification by HPLC (solvent
0.05% HCl in H2O; λ = 254 nm; flow rate 25 ml min–1; the product was collected at
31.5–41.0 min). IR: 3400s, 2955s, 2770s, 2550s, 2348w, 1635s, 1610s, 1505s, 1255m, 1088s,
1058s, 922m. 1H-NMR (D2O): 7.69 (d, J = 8.9, 2 arom. H); 6.97 (d, J = 8.9, 2 arom. H);
3.48 (t, J = 6.7, 2 H); 3.27–3.02 (m, 14 H); 2.24–1.95 (m, 6 H); 1.84–1.72 (m, 4 H). 13C-
NMR (D2O): 174.9 (s, CO); 163.5 (s, 1 arom. C); 133.7 (d, 2 arom. C); 129.2 (s, 1 arom.
C); 119.8 (d, 2 arom. C); 51.4 (t, 2 C); 49.9 (t); 49.0 (t, 2 C); 48.8, 42.9, 40.9, 30.0, 28.4,
27.1 (6t); 27.0 (t, 2 C). MS see paragraph 7.
5.4. N-(16-Amino-4,8,12-triazahexadecyl)-2,5-dihydroxybenzamide (2,5-(OH)2-Bz3334, AG
395b). Treatment of 12 (1.62 mmol) according to GP 5.1 afforded 2,5-(OH)2-Bz3334·4
TFA (281 mg, 0.33 mmol; overall 20% with respect to 1) after purification by HPLC
(solvent A: 0.05% TFA in MeOH; solvent B: 0.05% TFA in H2O; 11% A; λ = 240 nm;
flow rate 25 ml min–1; the product was collected at 41.0–62.0 min). IR: 3360m, 3095m,
2880m, 1670s, 1605m, 1490m, 1425m, 1200s, 1165s, 1130s, 835m, 800m, 720s. 1H-NMR
(D2O): 7.10 (d, J = 3.1, 1 arom. H); 6.92 (dd, J = 3.1, 8.8, 1 arom. H); 6.80 (d, J = 8.8, 1
arom. H); 3.43 (t, J = 6.6, 2 H); 3.19–2.93 (m, 14 H); 2.15–1.88 (m, 6 H); 1.80–1.61 (m, 4
H). 13C-NMR (D2O): 174.1 (s, CONH); 167.1 (q, J = 36, 4 CO(TFA)); 154.9, 152.9 (2s, 2
arom. C); 125.9, 122.7 (2d, 2 arom. C); 121.3 (s, 1 arom. C); 120.7 (q, J = 291, 4 CF3);
118.6 (d, 1 arom. C); 51.5, 49.7 (2t); 49.0, 48.8 (2t, 2×2 C); 43.2, 40.6, 30.1, 28.3, 27.2 (5t);
27.0 (t, 2 C). MS see paragraph 7.
5.5. N-(16-Amino-4,8,13-triazahexadecyl)-1H-indole-3-acetamide (IndAc3343, AG 416).
Treatment of 13 (0.80 mmol) according to GP 5.1 afforded IndAc3343·4 HCl (45 mg,
0.08 mmol; overall 10% with respect to 1) after purification by HPLC (solvent A:
0.05% HCl in MeOH; solvent B: 0.05% HCl in H2O; 25% A; λ = 254 nm; flow rate 20
ml min–1; the product was collected at 17.9–19.5 min). IR: 3380s, 3325m, 2950s, 2750s,
2520m, 2405w, 1650s, 1535m, 1455m, 1060w, 780w, 740m. 1H-NMR (D2O): 7.67–7.49 (m,
2 arom. H); 7.38–7.15 (m, 3 arom. H); 3.76 (s, ArCH2); 3.28 (t, J = 6.5, NCH2); 3.23–3.01
(m, 10 H); 2.97–2.82 (m, 4 H); 2.19–1.92 (m, 4 H); 1.89–1.73 (m, 6 H). 13C-NMR (D2O):
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180.5 (s, CO); 140.8, 131.1 (2s, 2 arom. C); 129.7, 126.7, 124.1, 122.8, 116.6 (5d, 5 arom.
C); 112.2 (s, 1arom. C); 51.5 (t, 2 C); 49.6, 49.1 (2t); 48.9 (t, 2 C); 41.1, 40.4, 37.0, 30.1,
28.3 (5t); 27.3 (t, 2 C); 27.1 (t). MS see paragraph 7.
5.6. N-(16-Amino-4,8,13-triazahexadecyl)-4-hydroxybenzamide (4-OH-Bz3343). Treatment
of 14 (1.62 mmol) according to GP 5.1 afforded 4-OH-Bz3343·4 HCl (100 mg, 0.19
mmol; overall 12% with respect to 1) after purification by HPLC (solvent 0.06% HCl
in H2O; λ = 254 nm; flow rate 20 ml min–1; the product was collected at 42.5–49.0
min). IR: 3320m, 2950s, 2780s, 1640m, 1610m, 1510m, 1460m, 845m. 1H-NMR (D2O):
7.70 (d, J = 8.8, 2 arom. H); 6.96 (d, J = 8.8, 2 arom. H); 3.48 (t, J = 6.6, 2 H); 3.22–3.06
(m, 14 H); 2.22–1.94 (m, 6 H); 1.86–1.70 (m, 4 H). 13C-NMR (D2O): 175.2 (s, CO); 163.8
(s, 1 arom. C); 133.9 (d, 2 arom. C); 129.6 (s, 1 arom. C); 120.0 (d, 2 arom. C); 51.5 (t, 2
C); 49.8, 49.1 (2t); 49.0 (t, 2 C); 41.1, 41.0, 30.3, 28.3 (4t); 27.3 (t, 2 C); 27.2 (t). MS see
paragraph 7.
5.7. N-(16-Amino-4,8,13-triazahexadecyl)-2,5-dihydroxybenzamide (2,5-(OH)2-Bz3343).
Treatment of 15 (1.62 mmol) according to GP 5.1 afforded 2,5-(OH)2-Bz3343·4 HCl
(110 mg, 0.20 mmol; overall 12% with respect to 1) after purification by HPLC
(solvent A: 0.06% HCl in MeOH; solvent B: 0.06% HCl in H2O; 11% A; λ = 254 nm;
flow rate 20 ml min–1; the product was collected at 17.0–21.0 min). IR: 3425m, 3360m,
2950s, 2750s, 1645w, 1600m, 1490s, 1230m, 820m, 790w. 1H-NMR (D2O): 7.09 (d, J = 3.0,
1 arom. H); 6.93 (dd, J = 3.0, 8.9, 1 arom. H); 6.82 (d, J = 8.9, 1 arom. H); 3.46 (t, J = 6.7,
2H); 3.23–3.04 (m, 14 H); 2.23–1.95 (m, 6 H); 1.84–1.74 (m, 4 H). 13C-NMR (D2O): 174.0
(s, CO); 155.2, 152.8 (2s, 2 arom. C); 126.0, 122.7 (2d, 2 arom. C); 121.4 (s, 1 arom. C);
118.5 (d, 1 arom. C); 51.5 (t, 2 C); 49.9, 49.10, 49.06, 49.0, 41.2, 40.8, 30.2, 29.3 (8t); 27.3
(t, 2 C); 27.2 (t). MS see paragraph 7.
5.8. N-(16-Amino-4,9,13-triazahexadecyl)-1H-indole-3-acetamide (IndAc3433). Treatment
of 19 (1.55 mmol) according to GP 5.1 afforded IndAc3433·4 HCl (105 mg, 0.19 mmol;
overall 12% with respect to 1) after purification by HPLC (solvent A: 0.05% HCl in
MeOH; solvent B: 0.05% HCl in H2O; 12.5% A; λ = 220 nm; flow rate 20 ml min–1; the
product was collected at 25.5–36.5 min). IR: 3400s, 3300m, 2950s, 2750s, 2490m, 1650m,
1610w, 1455m, 740m.1H-NMR (D2O): 7.67–7.47 (m, 2 arom. H); 7.38–7.16 (m, 3 arom.
H); 3.77 (s, ArCH2); 3.34–2.65 (m, 16 H); 2.22–2.07 (m, 4 H); 1.89–1.54 (m, 6 H). 13C-
NMR (D2O): 180.5 (s, CO); 140.9, 131.1 (2s, 2 arom. C); 129.7, 126.7, 124.1, 122.9, 116.6
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(5d, 5 arom. C); 112.3 (s, 1 arom. C); 51.5, 51.3, 49.4, 49.3, 49.2, 49.0, 41.1, 40.5, 37.0,
30.1, 28.3 (11t); 27.2 (t, 2 C); 27.1 (t). MS see paragraph 7.
5.9. N-(16-Amino-4,9,13-triazahexadecyl)-4-hydroxybenzamide (4-OH-Bz3433). Treatment
of 20 (1.62 mmol) according to GP 5.1 afforded 4-OH-Bz3433·4 TFA (159 mg, 0.2
mmol; overall 12% with respect to 1) after purification by HPLC (solvent A: 0.05%
TFA in MeOH; solvent B: 0.05% TFA in H2O; 0–65 min 5% A; 65–100 min 20% A; λ =
254 nm; flow rate 20 ml min–1; the product was collected at 83.5–89.1 min). IR: 3400m,
3100m, 2880m, 1670s, 1605m, 1510m, 1475m, 1425m, 1200s, 1160s, 1130s, 835m, 800m,
720s.1H-NMR (D2O): 7.61 (d, J = 8.8, 2 arom. H); 6.88 (d, J = 8.8, 2 arom. H); 3.40 (t, J =
6.6, 2 H); 3.16–2.97 (m, 14 H); 2.18–1.86 (m, 6 H); 1.78–1.66 (m, 4 H). 13C-NMR (D2O):
175.0 (s, CONH); 167.1 (q, J = 36, 4 CO(TFA)); 163.7 (s, 1 arom. C); 133.8 (d, 2 arom. C);
129.5 (s, 1 arom. C); 120.7 (q, J = 291, 4 CF3); 119.9 (d, 2 arom. C); 51.4, 51.3, 49.6, 49.1,
49.0, 48.8, 41.0, 40.9, 30.2, 28.2 (10t); 27.2 (t, 2 C); 27.1 (t). MS see paragraph 7.
5.10. N-(16-Amino-4,9,13-triazahexadecyl)-2,5-dihydroxybenzamide (2,5-(OH)2-Bz3433).
Treatment of 21 (1.64 mmol) according to GP 5.1 afforded 2,5-(OH)2-Bz3433·4 TFA
(182 mg, 0.21 mmol; overall 13% with respect to 1) after purification by HPLC
(solvent A: 0.05% TFA in MeOH; solvent B: 0.05% TFA in H2O; 0–75 min 9% A;
75–100 min 20% A; λ = 240 nm; flow rate 25 ml min–1; the product was collected at
86.5–90.0 min). IR: 3380m, 3095m, 2890m, 1670s, 1600m, 1480w, 1425w, 1200s, 1165s,
1135s, 835w, 800m, 720m. 1H-NMR (D2O): 7.12 (d, J = 3.1, 1 arom. H); 6.96 (dd, J = 3.1,
9.0, 1 arom. H); 6.85 (d, J = 9.0, 1 arom. H); 3.47 (t, J = 6.7, 2 H); 3.23–3.04 (m, 14 H);
2.25–1.93 (m, 6 H); 1.85–1.71 (m, 4 H). 13C-NMR (D2O): 174.0 (s, CONH); 167.0 (q, J =
36, 4 CO(TFA)); 155.1, 152.8 (2s, 2 arom. C); 126.4, 122.6 (2d, 2 arom. C); 121.4 (s, 1
arom. C); 120.6 (q, J = 291, 4 CF3); 118.5 (d, 1 arom. C); 51.2, 49.5, 49.1 (3t); 49.0 (t, 2 C);
48.8, 40.9, 40.6, 30.1, 28.1 (5t, 5 C); 27.1 (t, 2 C); 27.0 (t). MS see paragraph 7.
5.11. N-(16-Amino-5,9,13-triazahexadecyl)-1H-indole-3-acetamide (IndAc4333, AG 416b).
Treatment of 16 (1.55 mmol) according to GP 5.1 afforded IndAc4333·4 HCl (97 mg,
0.173 mmol; ovrall 11% with respect to 1) after purification by HPLC (solvent A:
0.05% HCl in MeOH; solvent B: 0.05% HCl in H2O; 12.5% A; λ = 220 nm; flow rate 20
ml min–1; the product was collected at 31.5–42.0 min). IR: 3380s, 3320m, 2950s, 2750s,
2490m, 2410m, 1655m, 1610w, 1525m, 1455m , 1050w, 770w , 740m.1H-NMR (D2O):
7.55–7.40 (m , 2 arom. H); 7.25–7.03 (m, 3 arom. H); 3.63 (s, ArCH2); 3.14–2.95 (m, 12
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H); 2.91–2.80 (m, 4 H); 2.10–1.87 (m, 6 H); 1.53–1.33 (m, 4 H). 13C-NMR (D2O): 179.9 (s,
CO); 140.9, 131.2 (2s, 2 arom. C); 129.6, 126.6, 124.0, 122.9, 116.6 (5d, 5 arom. C); 112.3
(s, 1 arom. C); 51.7, 49.3 (2t); 49.1 (t, 3 C); 48.6, 43.1, 41.1, 37.1, 30.1, 28.3, 27.3, 27.2,
27.1 (9t). MS see paragraph 7.
5.12. N-(16-Amino-5,9,13-triazahexadecyl)-4-hydroxybenzamide (4-OH-Bz4333, AG 379a).
Treatment of 17 (1.64 mmol) according to GP 5.1 afforded 4-OH-Bz4333·4 HCl (250
mg, 0.48 mmol, 30% with respect to 1) without further purification. IR: 3320s, 2955s,
2755s, 2480s, 2415s, 2020w, 1860w, 1635s, 1610s, 1508s, 1450s, 1270m, 1165m, 1050s,
850m, 770s. 1H-NMR (D2O): 7.66 (d, J = 8.8, 2 arom. H); 6.93 (d, J = 8.8, 2 arom. H); 3.37
(t, J = 6.7, 2 H); 3.26–3.05 (m, 14 H); 2.23–2.04 (m, 6 H); 1.82–1.59 (m, 4 H). 13C-NMR
(D2O): 174.7 (s, CO); 163.6 (s, 1 arom. C); 133.8 (d, 2 arom. C); 129.9 (s, 1 arom. C);
119.9 (d, 2 arom. C); 52.0, 49.2, 49.13 (3t); 49.09 (t, 2 C); 48.8, 43.4, 41.0, 30.3, 28.2, 27.5
(6t); 27.1 (t, 2 C). MS see paragraph 7.
5.13. N-(16-Amino-5,9,13-triazahexadecyl)-2,5-dihydroxybenzamide (2,5-(OH)2-Bz4333,
AG 395c). Treatment of 18 (1.62 mmol) according to GP 5.1 afforded 4-OH-Bz3334·4
HCl (200 mg, 0.37 mmol; overall 23% with respect to 1) without further purification.
IR: 3423s, 2956s, 2756s, 2496s, 2415s, 1690w, 1650m, 1603s, 1590s, 1460s, 1265m, 1050s.
1H-NMR (D2O): 7.13 (d, J = 3.1, 1 arom. H); 6.97 (dd, J = 3.1, 8.8, 1 arom. H); 6.87 (d, J =
8.8, 1 arom. H); 3.41 (t, J = 6.5, 2 H); 3.26–3.08 (m, 14 H); 2.22–2.05 (m, 6 H); 1.84–1.63
(m, 4 H). 13C-NMR (D2O): 173.7 (s, CO); 155.0, 152.9 (2s, 2 arom. C); 125.9, 122.8 (2d, 2
arom. C); 122.0 (s, 1 arom. C); 118.6 (d, 1 arom. C); 51.9, 49.3 (2t); 49.1 (t, 3 C); 48.8,
43.3, 41.1, 30.1, 28.3, 27.5 (6t); 27.2 (t, 2 C). MS see paragraph 7.
6. 2-{1-[(tert-Butyl)dimethylsilyl]-1H-indole-3}-acetic acid. To 1H-Indole-3-acetic acid (1.3
g, 7.4 mmol) in DMF (15 ml) at 0° was added NaH (0.445 g, 18.6 mmol). After 30 min
at 0°, (t-Bu)Me2SiCl (1.23 g, 8.1 mmol) was added. The soln. was stirred for 1 h at 0°,
poured into H2O (200 ml), and acidified with 10% aq. HCl soln. Crystallisation of the
acid formed was completed by cooling the soln. to 4° for 30 min. The colorless
precipitate was filtered off, washed with H2O, and dried in vacuo for 15 h to give
TBSIndAcOH (2.00 g, 6.9 mmol; 93%). M.p. (H2O): 144–145°. IR: 3400s, 2929s, 1709s,
1452s, 1316s, 1258m, 1216m, 1139s, 970s, 739s. 1H-NMR (CDCl3): 10.08 (br s, COOH);
7.65–7.69 (m, 2 arom. H); 7.22–7.11 (m, 3 arom. H); 3.80 (s, CH2); 0.94 (s, t-Bu); 0.60 (s,
2 Me). 13C-NMR (CDCl3): 177.9 (s, CO); 141.3, 130.5 (2s, 2 arom. C); 130.0, 121.7 (2d, 2
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arom. C); 119.8 (s, 1 arom. C); 118.8, 114.0 (d, 2 arom. C); 109.7 (s, CCH2); 31.2 (t, CH2);
26.3 (q, Me3C); 19.4 (s, Me3C); –4.0 (q, Me2Si). CI-MS: 290 (100, [M + H]+).
7. HPLC-UV(DAD)-APCI-MS and -MS/MS Investigation. 7.1. Equipment and Conditions.
Solvents and reagents: MeCN (HPLC grade, Scharlau, E-Barcelona); TFA, purum
(Fluka, CH-Buchs). H2O was purified with an MILLI-QRG apparatus (Millipore,
Milford, MA, USA). Venom preparation: lyophilized venom (5.0 mg) was dissolved
at 23° in TFA soln. (1% TFA in H2O/MeCN 3:2, 60 µl). The hazy soln. was filtered
through a 0.45 µm filter (Eppendorf, D-Hamburg), and the filter was rinsed with H2O
(20 µl). The combined filtrates provided the clear stock soln. that was stored at –20°
and was used for the following HPLC-MS investigations. Samples of 1–5 µl of the
venom stock soln., of 1–5 µl of a toxin stock soln. (1 mM synthetic polyamine
derivatives in 0.75% TFA in H2O/MeCN 7:3)), or of a 1:1 mixture of venom/toxin
stock soln. were injected for the individual runs and were analyzed by HPLC-
UV(DAD), HPLC-UV(DAD)-APCI-MS, and HPLC-UV(DAD)-APCI-MS/MS.
HPLC-UV(DAD): Instrumentation: Waters 626-LC system, fitted to a 996 photodiode-
array detector, a 600S controller, a Millennium Chromatography Manager 2010 v. 2.15
(Waters Corp., Milford, MA, USA), and a Rheodyne-Rotary-7725i rotary valve with a 5-
µ l loop (Rheodyne, Cotati, CA, USA). Column and chromatographic conditions:
Macherey-Nagel C18  HD column (3 µm, 4.6 × 250 mm; Macherey-Nagel, F-Hoerdt); flow
rate 0.5 ml min–1. Mobile phase: step gradient over 5 min from 0 to 10 % of solvent B,
then over 75 min from 10 to 45% of B, and finally over 20 min from 45 to 100% of B
(solvent A: 0.1% soln. of TFA in H2O, solvent B: 0.1% soln. of TFA in MeCN).
MS: APCI-MS and APCI-MS/MS experiments were performed on a Finnigan-TSQ-
700 triple-stage quadrupole instrument equipped with an atmospheric-pressure
chemical-ionization (APCI) ion source (Finnigan, San José, CA, USA). The APCI
operating conditions in positive mode were: vaporizer temp. 450°; corona voltage 5
kV; heated capillary temp. 250°; sheath gas N2 with an inlet pressure of 40 PSI;
conversion dynode: –15 kV. For MS/MS experiments: collision gas Ar with a relative
pressure of 2.5–3.3 mTorr; collision-induced dissociation offset (Coff): –27 eV.
7.2. Results of the ESI-MS/MS Investigation. See Tables 2–4.
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Table 2. MS/MS Signals of Natural and Synthetic Compounds with Quasi-Molecular Ions
m/z 417 (IndAc-Pentamines).
m/z Signals and retention times
Natural venom Synthetic samples with the IndAc group
attached to the polyamines
tR = 26.0 tR = 27.5 tR = 26.0
PA3334
(AG 416a)
tR = 26.0
PA3343
(AG 416)
tR = 26.0
PA3433
(—)
tR = 27.5
PA4333
(AG 416b)
58 2 2 — — — 4
70 — 5 — — — 4
72 6 4 11 2 — 4
84 4 9 4 6 3 3
98 15 49 25 — 6 65
112 59 41 46 100 53 11
115 16 36 19 — 19 46
127 — 3 — — — —
129 18 9 8 55 3 3
130 10 5 10 4 9 5
132 2 4 1 — 1 2
144 — 2 — — — 1
155 — 4 — — — 3
158 1 2 2 1 — 2
159 1 1 2 1 2 2
169 5 7 7 — 1 —
170 — 6 — — — 1
172 1 34 1 — — 41
186 24 4 11 3 40 2
187 4 2 — 1 2 3
189 2 2 2 — — 2
203 1 2 1 — — —
215 100 22 100 58 100 1
228 2 4 1 — — 5
229 — 16 — — — 24
241 — 2 — — — 1
243 2 2 3 — — 1
258 — 3 — — — 2
260 3 9 3 — — 9
268 — — — — — 1
272 29 9 45 22 — 3
286 21 81 — 1 46 92
289 7 4 7 12 — —
303 — 19 — — — 25
311 8 2 10 — — —
325 4 3 — 14 — 2
328 13 3 22 — — —
329 11 4 22 — — —
343 7 37 — 20 — 45
346 19 10 26 — — —
360 — 3 — — — 3
382 5 1 8 — — —
399 18 6 25 4 — 3
400 10 7 13 — — 8
417 26 100 25 2 4 100
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Table 3. MS/MS Signals of Natural and Synthetic Compounds with Quasi-Molecular Ions
m/z 380 (4-OH-Bz-Pentamines).
m/z Signals and retention times
Natural venom Synthetic samples with the 4-OH-Bz group
attached to the polyamines
tR = 16.7 tR = 17.8 tR = 16.7
PA3334
(—)
tR = 16.7
PA3343
(AG 379)
tR = 16.7
PA3433
(—)
tR = 17.8
PA4333
(AG 379a)
44 1 2 — — — 2
58 2 5 1 2 — 3
70 3 3 — — — 2
72 18 3 15 3 — 2
84 9 3 5 9 3 3
98 24 82 29 — 8 100
112 81 33 48 100 51 16
115 22 54 17 — 18 49
121 14 18 11 5 12 15
129 25 7 12 46 1 5
132 3 4 1 — 2 4
138 — 4 — — — —
148 — — 1 — — —
150 2 3 1 — — —
155 — 4 — — — 2
169 8 3 7 — — —
172 3 34 3 — — 39
176 — 2 — — — —
178 100 10 100 48 100 1
186 9 4 8 1 18 2
189 1 2 4 — —
191 5 3 2 2 —
192 — 42 — — — 34
203 2 — — — — —
205 — 2 — — — —
206 — — 1 — — —
207 2 — 2 — — —
220 — — 2 — — —
221 2 2 — — — —
235 49 10 34 18 — 2
243 3 5 9 — — 2
249 3 100 — — 25 85
252 10 2 11 5 — —
260 5 31 9 — — 22
266 — 12 — — — 16
274 7 — 7 — — —
288 4 2 — 4 — 2
292 24 3 19 — — —
306 5 43 — 11 — 38
309 23 3 11 — — —
322 — — — — — 3
323 — 3 — — — —
345 2 — 4 — — —
362 11 5 10 1 — 3
363 5 5 9 — — 5
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Table 4. MS/MS Signals of Natural and Synthetic Compounds with Quasi-Molecular Ions
m/z 396 (2,5-(OH)2-Bz-Pentamines).
m/z Signals and retention times
Natural venom Synthetic samples with the 2,5-(OH)2-Bz group
attached to the polyamines
tR = 19.5 tR = 21.8 tR = 19.5
PA3334
(AG 395b)
tR = 19.5
PA3343
(—)
tR = 19.5
PA3433
(—)
tR = 21.8
PA4333
(AG 395c)
44 3 8 — — —
58 2 6 2 3 1 3
70 6 6 2 — — 4
72 25 — 27 2 — 3
84 5 7 6 7 3 3
98 39 91 44 — 9 100
112 100 29 69 100 55 15
115 28 47 33 3 22 65
129 36 43 15 50 10 21
132 5 — 3 — 2 5
137 9 11 13 5 9 5
141 — — 1 — — —
146 — — — — — 2
155 — 11 — — — 3
166 4 — 2 1 4 —
169 11 — 8 — — 2
172 15 58 9 — — 37
186 16 29 10 10 22 12
189 12 7 15 — — 5
194 91 15 100 23 100 —
203 2 — 2 — — —
207 3 8 2 — — 4
208 — 24 — — — 14
223 3 — 1 — — —
237 — 12 — — — 2
243 13 16 15 — — 4
251 82 10 49 19 — 2
260 10 70 18 — 1 42
265 3 66 — — 38 70
268 11 — 5 4 — —
282 — 22 — — — 12
290 7 — 10 — — —
304 3 7 — 6 — —
308 46 10 28 — — —
322 8 100 — 17 — 55
325 27 14 29 — — —
338 — — — — — —
339 — 9 — — — 3
361 6 — 4 — — —
378 21 — 11 — — 1
379 21 12 10 — — 5
396 30 32 18 — 2 61
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CHAPTER 2
Tandem Mass Spectrometric Investigation of Acylpolyamines of Spider Venoms
and their 15N-Labeled Derivatives1
Abstract
The fragmentation mechanism of the acylpentamine toxins 1–4 found in the venom
of the spider Agelenopsis aperta has been investigated in detail. To identify the origin
of the two doublets of unexpected fragment ions at m/z 129/112 and m/z 115/98,
three synthetic 15N-labeled analogs 5–7 have been prepared and subjected to CID
fragmentation on a triple quadrupole mass spectrometer. It appears that the
unexpected doublet of fragment ions arises from an internal portion of the
polyamine backbone after either a transaminative Zip-reaction or a sequential
fragmentation of the quasi-molecular ion. The second option has been proven by in-
source CID experiments. The detailed knowledge of acylpentamine fragmentation
mechanisms is essential for the correct characterization of isomeric compounds,
particularly for co-eluting compounds within complex mixtures such as spider
venoms.
Introduction
Polyamines and polyamine-containing alkaloids are widely found throughout the
plant and animal kingdom [1, 2]. Over the past decades, spider venoms, particularly
their fractions containing acylpolyamine derivatives [1, 3, 4], have increasingly
attracted the attention of scientists. With the advent of more sensitive and selective
analytical methods — in particular of the modern mass spectrometric approaches —
not only the major but also minor constituents of such trace toxin sources became
amenable to detection and structural elucidation. Only recently have we
demonstrated with the reinvestigation of the venom of the spider Agelenopsis aperta
(Agelenidae) that this toxin cocktail contains in addition to the previously found 11
                                                 
1 M. Tzouros, N. Manov, S. Bienz, L. Bigler, J. Am. Soc. Mass Spectrom. 2004, 15, 1636.
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major acylpolyamines, 27 further minor components that evaded earlier
investigations [5, 6].
The detection and structural elucidation of these spider toxins relied particularly on
the on-line coupled high-performance liquid chromatography, UV diode array
detection, and atmospheric-pressure chemical ionization mass spectrometry (HPLC-
UV(DAD)-APCI-MS and -MS/MS). This arrangement allowed the efficient
separation and investigation of the several venom components, making most
economical use of the precious sample material. The structural elucidations,
however, would not have been possible if a profound knowledge of the
fragmentation behavior of the parent class of compounds had not been available,
especially in the case of co-eluting isomers. While most of the toxins of A. aperta were
disclosed on the basis of pure ‘MS investigations’ by comparison of fragmentation
patterns observed and explained during previous investigations, five of them were
only revealed by their comparison with synthetic material [6]. But also in these cases,
their identity could only be revealed because of the specific fragmentation behavior
of several structural isomers that could only be studied, however, with the pure
sample compounds. On the whole, the knowledge of the fragmentation patterns of
polyamines and also the deeper understanding of the respective fragmentation
mechanisms proved an important prerequisite to allow efficient and definitive
identification and characterization of known and new polyamine derivatives by MS
methods.
In the course of our investigation of the venom of A. aperta, we have studied the
fragmentation behavior of acylpolyamines extensively and have also discussed
possible fragmentation paths and mechanisms [5]. For some groups of isomeric
acylpentamines, however, inconsistencies with regard to expected fragmentation
patterns surfaced. Concentrating solely on the proposed fragmentation reaction for
the ‘loss of the terminal diaminopolymethylene unit’, the occurrence of fragments of
the types a  and b  — formed upon collision induced dissociation (CID) by
intramolecular nucleophilic substitutions (sNi) according to Scheme 1 — were thought
to be indicative for the identification of the terminal diamine portions of the toxins.
However, this is only true with reservation. For instance, the toxins IndAc43332 (1)
                                                 
2The expression IndAc4333 stands for a linear pentamine possessing 4, 3, 3, and 3 methylene units
between the several N-atoms, whereby the IndAc group is located at the N-atom which is followed by
the tetramethylene unit. IndAc is the abbreviation for 1H-indole-3-acetyl.
Chapter 2 47
and IndAc3433 (2) would be expected to give rise to fragments a333 (m/z 115) and b33
(m/z 98) and not to fragments a43/a34 (m/z 129) and b43 (m/z 112), while isomeric
IndAc3343 (3) and IndAc3334 (4) should produce fragments a43/a34 and b43 instead,
and none of the fragments a33 and b33.
− NH3
CID
N
H
m n
m=1, n=1 : a33,
m=2, n=1 : a43,
m=1, n=2 : a34,
m/z 129
IndAc4333 (1)
H
N
H2
N NH2R n
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Scheme 1. Mass spectral fragmentation of the terminal part of the [M + H]+ ions of the
IndAc pentamine derivatives 1–4.
                                                 
3 The subscripts denote the number of methylene groups contained in the two chains or rings.
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Figure 1. ESI-MS/MS of the [M + H]+ ions at m/z 417 of a) IndAc4333 (1), b) IndAc3433
(2), c) IndAc3343 (3), and d) IndAc3334 (4).
Unexpected fragment ions are indicated by an arrow.
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In reality, however, the CID spectra deriving from the two quasi-molecular ions of
synthetic IndAc4333 and IndAc3433 also showed signals at m/z 129 and 112, which
should be indicative for a terminal PA34 or PA43 unit4, and in the case of IndAc3334
(but not of IndAc3343!), signals at m/z 115 and 98 were additionally found, which
would imply a PA33 end-portion for the molecule (Figure 1). The feature of
exhibiting unexpected signals of such types is not specific to pentamines bearing the
IndAc moiety; it is also characteristic for other pentamine derivatives that bear, e.g., a
4-hydroxybenzoic or a 2,5-dihydroxybenzoic group in place of IndAc (spectra not
shown here).
N
H
H
N
O
H
N
H
N
H
N
NH2
H2N
H
N N
H
N
NH2
N
H
H
N
O
N
H
N NH2
NH2
O
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+ H+
[M + H]+
IndAc3334 (4), m/z 417
H
CID
− IndAc34
a33
m/z 115
Pathway A
transamidative
Zip reaction
A, m/z 417
B, m/z 417
Pathway B
transaminative
Zip reaction
H
– NH3
b33
m/z 98
CID
− IndAc34
a33
m/z 115 – NH3
b33
m/z 98
CID
CID
Scheme 2. Possible gas phase rearrangements of the [M + H]+ ions of IndAc3334 (4).
As an explanation for the peculiar MS behavior of the acylpentamines, we have
offered two plausible reaction paths involving an acid promoted transamidative
(Pathway A) or transaminative (Pathway B) Zip-reaction [7], as outlined in Scheme 2
                                                 
4PA34 stands for a linear triamine with 3 and 4 methylene units (in this succession) between the
terminal and internal N-atoms [2]. The nomenclature is also used for more extended polyamines.
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in the case of IndAc3334 (4). For both transformations, precedence is available in the
MS literature: transamidation reactions were discussed with respect to the MS
behavior of 4-hydroxycinnamoyl spermidines [8] as well as N ,N ’ -bis(4-
hydroxycinnamoyl) spermidines [9], and transamination reactions were considered
for polypropylenamine dendrimers [10] and for monoimidazole polyamine
conjugates [11]. The presence of the signal doublet at m/z 129/112 in the CID of
IndAc4333 would rather support the transamidative Pathway A while the lack of
signals at m/z 115/98 for IndAc3343 would suggest Pathway B proceeding through
transaminations.
To distinguish between these two paths, we have synthesized the three 15N-
containing IndAc3334 derivatives IndAc15N3334  (5 ), I n d A c 315N 3 3 4  (6 ), and
IndAc3315N34 (7) [12] (Figure 2). The three labeled isomers were then analyzed by ESI-
MS/MS, analogously to the unlabeled parent compound. The results of this MS
investigation are presented below.
N
H
Na
O
Nc
H
N
NH2
HH H
Na = 15N : IndAc15N3334 (5), [M + H]+ m/z 418
Nb = 15N : IndAc315N334 (6)
Nc = 15N : IndAc3315N34 (7)
Nb
Figure 2. Investigated 15N-labeled IndAc3334 derivatives 5–7.
Experimental Part
Material
All 15N-labeled acylpolyamine samples used were synthesized in our laboratory [12].
For ESI-MS, all compounds were dissolved in a 1:1 mixture of HPLC grade MeOH
(Scharlau, Barcelona, Spain) and H2O (purified with a Milli-QRG apparatus,
Millipore, Milford, MA) at a concentration of 50 nmol ml–1.
Mass Spectrometry
ESI tandem mass spectra were recorded with a TSQ 700 triple quadrupole mass
spectrometer (Finnigan MAT, San Jose, CA) equipped with a combined Atmospheric
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Pressure Ion (API) source. Samples were continuously introduced into the source
with a Syringe Pump 22 (Harvard Apparatus, Holliston, MA) at a flow rate of 5 µl
min–1. The ESI operating conditions in positive mode were: capillary voltage 4500 V;
heated capillary temperature 210°C; sheath gas N2 with an inlet pressure of 30 psi;
electron multiplier: 1000 V; conversion dynode: –15 kV; resolution: 0.7 u at half peak
height; scan rate: 900 Da s–1; 16 scans were averaged. For the CID experiments, Ar
was used as the collision gas with a relative pressure of 2.5–3.3 mTorr. The collision-
induced dissociation offset (Coff) was set to –27 V and the electron multiplier was set
to 1500 V. In-source CID spectrum was obtained by setting the octopole voltage at
–3 V, and fragment ions were further subjected to CID by setting the Coff voltage at
–22 V.
Results and Discussion
The ESI-MS/MS of the three labeled compounds 5–7 and of the unlabeled parent
compound 4 — all obtained under the same conditions from the respective [M + H]+
parent ions — are shown in Figure 3. Concentrating on the signals of type a and b, it
is readily recognized that the signals for the respective fragment ions a34/b435 at m/z
129/112 remained unaffected for all the 15N-containing compounds. However, the
signals for the a 33/b33 ions were recorded only for IndAc15N3334  (5) and
IndAc315N334 (6) at m/z 115/98 while they were found at masses higher by 1 Da (m/z
116/99) for IndAc3315N34 (7) and consequently designated as 15N-a33 and 15N-b33,
respectively.
These results unambigously show that the central portion of the polyamine moiety
(as indicated by the surrounded part of the compound in Figure 4) is incorporated in
the fragments a33/b33 deriving from compound 4. Therefore, the transamidative
Pathway A for the formation of these fragments is certainly not operative and can be
excluded. Otherwise, doublets for labeled fragments a33/b33 at m/z 116/98 or 116/99
should have been found for isomers 5 and 6, respectively. On the other hand, the
doublet of signals at m/z 116/99 for the 15N-containing fragments a33/b33 deriving
from isomer 7 is supportive for the transaminative Pathway B.
                                                 
5 The fragment ion at m/z 130 has been previously described as 3-methylene-3H-indolium (C9H8N+) [5]
and is not considered as labeled 15N-a43/a34.
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Figure 3. ESI-MS/MS of the [M + H]+ ions at m/z 417 of a) IndAc3334 (4), and at m/z
418 of labeled b) IndAc15N3334 (5), c) IndAc315N334 (6), and d) IndAc3315N34 (7).
15N-label containing a and b fragment ions are indicated by an arrow.
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Figure 4. Portion of the polyamine backbone of IndAc3334 responsible for the formation of
the fragment ions a33/b33 at m/z 115/98.
An alternative fragmentation path that was not seriously considered initially, but is
also consistent with the experimental data, is the sequential fragmentation of
acylpolyamines involving loss of a terminal aminoalkyl group in a first stage,
forming, e.g., for IndAc3334 the ion [IndAc333 + H]+. Such a secondary parent ion
could subsequently be fragmented according to the general rules (Scheme 3). This
would lead to fragments a33 and b33 that would consist of the same portions of the
parent molecule as those explained with the transamination/fragmentation pathway.
H
N
H
N
N
H
O
[M + H]+
IndAc3315N34 (7), m/z 418
15N
H
N
NH2
H
H
N
H2
N
N
H
O
15N NH2
H
−CID
[IndAc3315N3 + H]+, m/z 347
N
H
+ H+
CID − IndAc3
15N NH2
H
15N
− NH3
15N-a33, m/z 116 15N-b33, m/z 99
CID
Scheme 3. Sequential mass spectral fragmentation of the [M + H]+ ions
of IndAc3315N34 (7).
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However, if IndAc3334 dissociates by the usual sNi reaction by attack of the terminal
amino group at the CH2 group in α-position to the protonated secondary N-atom,
protonated pyrrolidine (see fragment ions at m/z 72 in Figure 3) and neutral IndAc333
is formed. Thus the observed [IndAc3315N3 + H]+ at m/z 347 from IndAc3315N34 (7)
cannot directly derive from this sNi reaction. In order to retain the charge on the
IndAc-end, a proton transfer process has to be operative. It is possible that a proton-
bound complex is formed during fragmentation, where the IndAc333-unit and
pyrrolidine compete for the H+. This mechanism was postulated to explain the
formation of the bn/yn ion series in the case of peptide fragmentation [13]. Support
for the sequential fragmentation of 4–7 is found with the signals at m/z 346 and 347,
corresponding to the proposed ions [IndAc333 + H]+ (Figure 3). That these ions are
formed rather easily is also demonstrated with the in-source CID experiment, which
involves very mild energy transfer and thus very mild fragmentation conditions,
performed with IndAc3315N34 (7) (Figure 5). By in-source CID, almost exclusively the
respective ions [IndAc3315N3 + H]+ registered at m/z 347 were formed. These ions,
selected by the first quadrupole and subjected to the usual CID by collision with Ar
in the collision cell, gave rise to a spectrum that exhibited, not surprisingly, signals at
m/z 116 and 99 for the 15N-labeled fragments of type a33 and b33.
Based on the experimental data acquired by the above experiments, both
mechanisms — dissociation of the quasi-molecular ion [IndAc3334 + H]+ through
transamination/fragmentation (Pathway B) or by sequential fragmentation via
intermediary [IndAc333 + H]+ ions — are feasible to explain to the formation of
fragments a34/b34 detected at m/z 129/115 in the ESI-MS/MS of compound 4. The
fact that [IndAc333 + H]+ is formed quite easily by in-source CID and that this ion is
also detected in the regular CID spectra talks in favor of the sequential fragmentation
path.
The behaviors of IndAc3433 (2) and IndAc3343 (3) are consistent with the two
fragentation paths discussed above as well. In the case of IndAc3433 (2), both loss of
azetidine or transamination would form intermediates that could give rise to
fragments a43 and b43 and thus to the observed signals at m/z 129/112 (see Figure 1b).
In this case, the signal for the secondary parent ion [IndAc343 + H]+ (m/z 360)
proposed for the stepwise pathway is not found in the spectrum, which is possibly
due to the fact that this ion should dissociate immediately after its formation to
Chapter 2 55
fragment a43 — and subsequently b43 — through a favored five-membered transition
structure as described above. For IndAc3343 (3), the doublet at m/z 129/112 can be the
response to the fragments a43/a34 and b34 deriving either by direct substitutive
fragmentation or by the more complex pathways discussed above (see Figure 1c). A
doublet at m/z 115/98 for a33 and b33 is not observed for this compound, however,
because [IndAc33 + H]+ (m/z 289), obtained by loss of terminal diaminoalkyl group,
cannot undergo fragmentation to these ions similarly to a free triamine.
Figure 5. In-source CID of the [M + H]+ ions at m/z 418 of labeled a) IndAc3315N34 (7),
and b) MS/MS of the secondary parent [IndAc3315N3 + H]+ ions at m/z 347.
In the case of IndAc4333 (1), the explanation for the formation of the ions of type
a43/a34 and b43 (see Figure 1a) is slightly different: loss of any portion of the molecule
from the amino terminus of the compound and also transaminations would never
lead to an intermediary species that could form these fragments. However, loss of the
acyl group and liberation of the protonated polyamine itself seems to be a favorable
CID-reaction for Acyl4 derivatives [6]. The respective signal for [PA4333 + H]+ is in
fact found at m/z 260 in the ESI-MS/MS of IndAc4333 (1), and decomposition of the
free polyamine can give rise to the fragments a43/a34 and b43. The corresponding
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[PA4333 + H]+ and [PA3433 + H]+ signals for compounds 2–4 are of low abundance
only or not observed at all (see Figure 1a-d). For Acyl3 derivatives, the alternative
formation of 4H-5,6-dihydro-1,3-oxazine species, represented in the spectra by the
strong signals at m/z 215, is the dominant reaction of the head portion [6].
Conclusion
We have shown that acylpolyamines can form some fragments in ESI-MS/MS that
are composed of internal portions of the polyamine moieties of the sample
molecules. From a mechanistic point of view, a fragmentation path involving a
transamidation was excluded. Two alternative mechanisms — by transamination
followed by fragmentation, or by two subsequent fragmentations — are possible and
cannot be distinguished. Signals of such fragments could lead to misinterpretations if
they were regarded to be derived from the end-portion of the compounds. Thus, for
the definite characterization and structural identification of acylpolyamines,
particularly those natural products of low abundance that lack synthetic references,
such fragments are of little relevance. Of more relevance is the overall fragmentation
pattern of the samples, which is dominated by the presence and location of 1,4-
diaminobutane subunits. Such subunits allow some specific and predominant
fragmentation reactions, occurring via five-membered transition structures. To
deduce a specific sample structure on the basis of MS behavior, it is consequently
necessary to judge the overall behavior of the considered compounds. In certain
cases, the structural deduction might even not be feasible directly without the
possibility to compare the sample compound with authentic samples.
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CHAPTER 3
New Linear Polyamine Derivatives in Spider Venoms1
Abstract
Linear free polyamines were characterized in the venom of the spiders Agelenopsis
aperta, Hololena curta, and Paracoelotes birulai by RP-HPLC coupled to mass
spectrometry. The several linear polyamines found were tetramine, pentamine, and
hexamine derivatives. Some of these natural products were identified as N-
hydroxylated, guanidylated, or acetylated compounds. In addition, the
biosynthetical pathway leading to the formation of acylpolyamines in spider venoms
is discussed.
Introduction
Spider venoms are known to be the source of a multitude of natural products and
particularly of acylpolyamines [1-3]. Although many acylpolyamines with rather
uncommon polyamine backbones were found in spider venoms, information about
the presence of the respective free non-derivatized bases is scarce in literature. Low
molecular weight biogenic amines such as the ubiquitous putrescine (PA4)2,
cadaverine (PA5), spermidine (PA34), and spermine (PA343) were characterized in
the mygalomorph spiders Scodra griseipes [5, 6], the Sydney funnel-web spider Atrax
robustus [7], and the species Dugesiella hentzi, Aphonopelma emilia and two further
Aphonopelma species [8]. The same biogenic amines along with histamine were also
reported in nine typical Japanese spider species [9]. Not in the venom but in the silk
glands and in the heads of the spiders Nephila clavata and Araneus ventricosus,
caldopentamine (PA3333) was found in addition to the more common biogenic
amines [10]. Apart from this last example, no information about spider derived, non-
acylated polyamines containing more than four N-atoms is found in literature. The
only natural sources for such extended polyamines, namely pentamines and
                                                 
1 M. Tzouros, S. Chesnov, S. Bienz, M. Hesse, L. Bigler, Toxicon 2005, 46, 0000.
2The abbreviation PA stands for polyamine; the figures designate the number of methylene in-
between the several N-atoms [4].
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hexamines, are bacteria. For example, homocaldopentamine (PA3334) [11] and
isomeric thermopentamine (PA3343) [12] were extracted from the thermophilic
eubacteria Thermus thermophilus  and homocaldohexamine (PA33334),
thermohexamine (PA33343), and homothermohexamine (PA33433) in Bac i l lus
schlegelii [13]. In these cases, also branched polyamines were characterized in
addition to the linear compounds. These polyamines from bacteria were identified
either by gas chromatography coupled to mass spectrometry (GC-MS) after their
derivatization with heptafluorobutyric anhydride (HFBA) [14], or by liquid
chromatography (LC) and fluorescence detection of the o-phthalaldehyde (OPA)
reaction products [15].
Recently, we have used high-performance liquid chromatography, on-line coupled
with atmospheric-pressure chemical ionization mass spectrometry (HPLC-
UV(DAD)-APCI-MS and MS/MS), to identify the acylpolyamine toxins contained in
the venom of the spiders Paracoelotes birulai (Amaurobiidae) [16] and Agelenopsis
aperta (Agelenidae) [17]. This instrumental setup allowed us to detect and
structurally elucidate polyamine derivatives directly, without an additional
derivatization step. For instance, a total of 38 compounds were characterized in A.
aperta [18], and it was shown, too, that for PA3343 and PA3334 all acylpentamine
isomers of the type Acyl33343, Acyl3343, Acyl3433, and Acyl4333 were present in the
toxin mixture. On the basis of this latter finding, we postulated that the biosynthetic
precursors of the acylpolyamines in spider venom might be the parent linear
polyamines that are ‘statistically’ mono-acylated at either terminal amino group of
the molecule.
To support these assumptions, we searched for free polyamines in the venoms of the
forementioned spiders P. birulai and A. aperta, as well in Hololena curta (Agelenidae).
Due to the absence of a chromophore on such compounds, UV detection was not
appropriate. Reverse-phase HPLC-APCI-MS was selected as the method of choice for
the separation and detection of linear polyamines.
Experimental Part
Lyophilized spider venom samples from A. aperta, H. curta, and P. birulai were
purchased from Fauna Laboratories, Ltd. (Almaty, Kazakhstan). A portion of the crude
venom (∼100 µg) was dissolved in MeCN/H2O (3:2) containing 0.1% of
                                                 
3 The different acyl groups linked to the polyamine backbones were 4-OH-Bz, 2,5-(OH)2-Bz, and IndAc.
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trifluoroacetic acid (TFA) and the stock solution stored at –20° prior to use.
Chromatographic separations were performed with an Interchim Uptisphere RP C18
column (UP3HDO–20QS, 3 µm, 4.6x200 mm; Intermchim, Montluçon, France) at a
flow rate of 500 µl min–1 gradients of MeCN/H2O/0.1% TFA from 0 to 10% over 5
min and from 10 to 15% over 10 min. The APCI-MS and MS/MS experiments were
performed on a Finnigan TSQ 700 (Finnigan, San José, CA, USA) triple quadrupole
instrument, and the base peak chromatograms (BPC) were obtained by monitoring
the ions with m/z between 100 and 1000.
Results and Discussions
The peaks observed in the chromatograms for the venom of the three spider species
were distributed over three different regions (Figure 1). The first fraction, containing
the linear polyamines, eluted with retention times (tR) close to 5 min. The second
fraction, eluting with tR between 10 and 12 min, was composed of pyrimidine and
purine derivatives. This class of compounds was found in the venom of the spider
Latrodectus menavodi and will not be further discussed here [19]. The third fraction,
eluting with tR between 12 and 15 min, consisted of acetyl- and guanidino-
substituted linear polyamines. The polyamine containing first fraction is rather
prominent in the venoms of both Agelenidae species A. aperta and H. curta, but little
abundant only in the venom of P. birulai. The mass spectra of the compounds co-
eluting at tR = 5.4 min in A. aperta (tR = 5.5 min in the case of H. curta) gave rise to the
quasi-molecular ions [M + H]+ at m/z 203, 219, 260, 276, 317, and 333.
Fragmentation by MS/MS of the respective [M + H]+ ions and interpretation of the
resulting daughter ions allowed the elucidation of their structure: the series of [M +
H]+ ions at m/z 203, 260, and 317 (the respective masses differing by 57 Da each)
correspond to the mixtures of tetramines PA343 and PA334, the pentamines PA3343
and PA3334, and the hexamines PA33433, PA33343, and PA33334, respectively (Table
1). The structure assignments are based on the comparison of the MS/MS data of the
linear polyamines with those of the parent acylpolyamine compounds and will be
discussed separately [20].
The second series of [M + H]+ ions, recorded at m/z 219, 276, and 333, were identified
as N-hydroxylated (+16 Da) derivatives of the tetramines, pentamines, and
hexamines mentioned above. However, according to their fragmentation patterns,
not all of the theoretically possible isomers of the N-hydroxydes are present in the
venoms.
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Figure 1. Reverse-phase HPLC-MS base peak chromatograms (BPC) of the venom of the
spiders A. aperta (a), H. curta (b), and P. birulai (c). Fractions containing linear
polyamines and derivatives thereof are indicated by an arrow.
The OH group was solely found to be connected to the secondary N-atoms linked to
terminal aminopropyl units. The compounds characterized are PA3(OH)43 and
PA3(OH)34 for [M + H]+ at m/z 219, PA3(OH)343 and PA3(OH)334 for [M + H]+ at m/z
276, PA3(OH)3343 and PA3(OH)3334 for [M + H]+ at m/z 333. To our knowledge, no
free N-hydroxylated linear polyamines have been isolated from a natural source
before.
Concentrating on the acetyl and guanidino derivatives, the chromatogram of the
venom of P. birulai shows two prominent signals at tR = 12.3 and 12.9 min. The MS of
the respective fractions reveal the presence of [M + H]+ ions at m/z 302, 318 (tR = 12.3
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min) and at m/z 344, 359, and 401 (tR = 12.9 min) (Figure 1c). MS/MS data of the first
fraction allowed the deduction of the structures PA3334Gu4 ([M + H]+ m/z 302) and
the N-hydroxylated derivative PA3(OH)334Gu ([M + H]+ m/z 318) [20]; the major
components of the second fraction were found to be the acetylated and/or
guanidylated derivatives Ac3334Gu ([M + H]+ m/z 344), PA33334Gu ([M + H]+ m/z
359), and Ac33334Gu ([M + H]+ m/z 401). The presence of the guanidino group at the
terminus of the polyamine backbone was already shown to be characteristic for
toxins from P. birulai [15]. H. curta revealed no guanidino derivatives but a bis-
acetylated polyamine, Ac33343Ac ([M + H]+ m/z 401), eluting with tR = 12.8 min
(Figure 1b). Acetylated polyamines were previously isolated solely from bacteria, e.g.,
N1-acetylcaldopentamine (Ac3333) from Staphilothermus hellenicus [21].
Conclusion
The linear polyamines found in the three spider species are supportive for the
biosynthesis previously proposed for the acylpolyamines [18]. The linear polyamines
arise probably from putrescine (PA4) by enzyme catalyzed repetitive addition of
aminopropyl units, as described in the literature for mammalian cells [22, 23]. Once
the linear polyamines are formed, they can be regiospecifically oxidized to the N-
hydroxylated derivatives. Interestingly, some bis-N-hydroxylated acylpolyamine
toxins are described for A. aperta [17] although no free linear polyamine containing
two N–OH moieties could be detected in the present study. Finally, the linear
compounds are acylated at either end of the polyamine backbone with one of the
known aromatic carboxylic acids 4-OH-BzOH, 2,5-(OH)2-BzOH, 2,4-(OH)2-PhAcOH,
IndAcOH, 4-OH-IndAcOH, and 6-OH-IndAcOH [1] to yield the acylpolyamines.
As already mentioned, underivatized linear free polyamines are of low abundance in
the case of P. birulai. All of the four compounds detected for this species possess a
guanidino end group attached to the aminobutyl portion of the polyamine backbone.
However, ‘regular’ acylpolyamine toxins, having no guanidino end group, are
present in the venom cocktail of P. birulai [16]. Elucidation of the complete
biosynthetic route to acylpolyamines has yet to be confirmed, e.g., by in-vivo
experiments.
                                                 
4 Gu designates a terminal guanidino group instead of a primary amine.
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CHAPTER 4
Two New Spermidine Alkaloids from Chisocheton weinlandii1
Abstract
The investigation of the MeOH extract of the leaves of Chisocheton weinlandii HARMS
(Meliaceae) revealed two new open-chain spermidine alkaloids, chisitine 1 (1) and
chisitine 2 (2). Their structures were elucidated by NMR spectroscopy, tandem-mass
spectrometry, and independent syntheses. Detailed MS/MS fragmentation pathways
are discussed for both compounds based on H/D exchange and 18O-labeling
experiments.
Introduction
Polyamine alkaloids are found in a large variety of natural sources including plants
and insects. These natural products are classified into two major categories
depending on whether the structure is cyclic or open-chained [1]. In general, such
polyamine alkaloids are composed of a putrescine (= butane-1,4-diamine),
spermidine (= N-(3-aminopropyl)butane-1,4-diamine), or spermine (= N,N’-bis(3-
aminopropyl)butane-1,4-diamine) backbone that carries one or more substituents at
the N-atoms, mostly acyl groups. Their determination was usually performed by a
combination of several analytical techniques, the methods of choice being mass
spectrometry combined with NMR spectroscopy.
However, NMR spectroscopy often does not securely assess the exact framework of
the polyamine portion within these alkaloids because of signal overlap of the
methylene protons. Furthermore, acyl-substituted polyamines display an additional
range of complexity in their NMR spectra due to s-cis/s-trans isomerism of the amide
functions. The NMR spectra of such isomer mixtures, exhibiting multiple signals for
the NMR active nuclei, always leave doubt about whether the sample was pure or
not.
                                                 
1 M. Tzouros, L. Bigler, S. Bienz, M. Hesse, A. Inada, H. Murata, Y. Inatomi, T. Nakanishi, D. Darnaedi,
Helv. Chim. Acta 2004, 87, 1411.
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Mass spectrometry  in combination with tandem-mass spectrometry (MS/MS) 
is gaining more and more importance in the identification and characterization of
polyamine alkaloids. Due to their high basicity and low volatility, polyamines are
excellent candidates for mass-spectrometric identification by means of electrospray
ionization (ESI-MS). This method allows to delimite the number of N-atoms present
in the molecule. In addition, MS/MS experiments can provide precious information
on the polyamine backbones and on the attachment sites of substituents.
Furthermore, as compared to NMR spectroscopy, data acquisition for MS is much
faster, and requires considerably smaller amounts of material.
In connection with our ongoing search for new polyamine alkaloids from plants and
animal sources, we were interested in the MeOH extracts of the leaves of Chisocheton
weinlandii HARMS (Meliaceae). This tree is distributed throughout southern Irian Jaya
(Papua New Guinea, Indonesia). Around fifty putrescine alkaloids have already been
characterized from species belonging to the plant family of Meliaceae [1]. Several
Chisocheton species have been screened for their natural-product content; among
them, Chisocheton paniculatus HIERN has been intensively investigated. Five apo-
tirucallol derivatives and four tetranortriterpenoids from the wood and seeds of C.
paniculatus were identified [2]. Four meliacin-type compounds were found in the
fruits [3], and five protolimonoids (called paniculatin B, C, D, G, and H) and one
limonoid (named arunachalin) were isolated and identified from the mature wood of
the plant [4]. For C. weinlandii, on the other hand, no study of the chemical
constituents is found in the literature. Only some insecticidal activity was reported
for extracts of its leaves and twigs [5]. These extracts showed inhibition to larval
growth of the variegated cutworm Peridroma saucia HÜBNER (Noctuinidae). We have
now studied the constituents of the leaves of the plant and isolated the two new
spermidine-type alkaloids 1 and 2 (see Figure 1). Their structures were established on
the basis of NMR spectroscopy, tandem-mass spectrometry, and comparison with
their synthetic equivalents.
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Results and Discussion
Isolation
Extraction of the crushed leaves of C. weinlandii with MeOH and distribution of the
extract between H2O and AcOEt yielded a crude mixture that was separated by
column chromatography (silica gel). With the eluent CHCl3/MeOH 5:1, a mixture
was obtained that was further subjected to semi-preparative reversed-phase HPLC,
resulting in the isolation of two pure compounds named chisitine 1 (1) and chisitine 2
(2) (Figure 1). To the best of our knowledge, these are the first spermidine alkaloids
isolated from a Meliaceae species.
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Figure 1. Structure and selected HMBC data of chisitine 1 (1) and 2 (2).2
Structure Elucidation
Chisitine 1 (1) shows in its ESI-MS a series of three peaks at m/z 378 ([M + H]+), 400
([M + Na]+), and 416 ([M + K]+) that allow the assignment of its relative molecular
mass as 377. The value suggests the presence of an odd number of N-atoms in the
molecule. The 1H- and 13C-NMR spectra of 1, showing a 1:1 ratio of two isomers (for
                                                 
2 Arbitrary numbering; for systematic name, see Experimental Part.
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data, see isomers 1a, and 1b in Tables 1 and 2), indicate the presence of a cinnamoyl
(= (2E)-3-phenylprop-2-enoyl) substituent. In the 1H-NMR spectrum of 1, the two
doublets at δ 7.10, 7.05 and the broad doublet at δ 7.49 (3J = 15.4) are attributed to the
olefinic protons H–C(2’) and H–C(3’) of the two isomeric forms 1a and 1b. The
corresponding 13C-NMR signals for C(2’) and C(3’) are found at δ 118.4 and 118.3,
and 141.3 and 141.2 and secured by HSQC. The signals at δ(C) 161.0, 160.9 (for 1a and
1b) and the broad singulet at δ(H) 8.00 suggest the presence of a formamide function
[6]. A third substituent is identified by the signal at δ(H) ca. 2.20 (3 H), which
correlates to the quadruplet (determined by DEPT) at δ(C) 11.5 (two overlapping
signals). These signals are attributed to the unusual MeSC(O)N residue. The
analytical data are in accordance with other carbamothioate-containing alkaloids [7,
8].
The presence of the MeSC(O)N group is further supported by the MS/MS results: the
intense fragment ion l (m/z 330), corresponding to the loss of 48 Da from the quasi-
molecular ion ([M + H]+) at m/z 378, indicates an easy loss of MeSH (see Figure 3a, in
Tandem-Mass Spectrometry of Chisitines 1 and 2). 1H-NMR Signals registered between δ
1.36 and 3.49 ppm (integrating for 14 H) and the 13C-NMR signals found between δ
26.3 and 46.8 ppm (all triplets) suggest a spermidine backbone for the compound.
The sites of attachment of the three substituents at the polyamine core, as well as the
detailed assignments of the signals, were finally established on the basis of the
MS/MS analysis (see next paragraph) as well as on the basis of the HMBC
experiment (selected HMBC data in Figure 1). After detailed analysis of further NMR
and MS data, the structure of chisitine 1 (1) was elucidated as S-methyl [3-{[4-
(formylamino)butyl][(2E)-3-phenylprop-2-enoyl]amino}propyl]carbamothioate. This
compound was synthesized, and the synthetic product was found to be identical
with the natural product with respect to all its spectroscopic data (see Synthesis of
chisitine 1 and 2).
The second compound, chisitine 2 (2), shows three adduct ions in the ESI-MS at m/z
408 ([M + H]+), 430 ([M + Na]+), and 446 ([M + K]+), consistent with a relative
molecular mass of 407. This indicates that chisitine 2 also contains an odd number of
N-atoms. The 1H- and 13C-NMR spectra of this alkaloid show the presence of the
same 1:1 ratio of two isomers as found for 1 (for data, see isomers 2a and 2b in Tables
1 and 2).
Chapter 4 71
Table 1. 1H-NMR Data (500.1 or 600.1 MHz, (D6)DMSO) of Chisitines 1 (1) and 2 (2).
δ in ppm, J in Hz.
1a) 2b)
Isomer 1a Isomer 1b Isomer 2a Isomer 2b
H–N(1) 8.23 (br. s) 8.11 (br. s) 8.49–8.47 (m) 8.57–8.55 (m)
CHO
H–N(10) 8.00 (br. s)
c) 8.00 (br. s)c)
H–C(3’’) — 7.87 (d, J = 7.4) 7.85 (d, J = 7.4)
H–C(5’) 7.70–7.68 (m)c) 7.71 (d, J = 7.4) 7.58 (d, J = 7.1)
H–C(5’’) —
H–C(3’) 7.49 (br. d, J ≈ 15.2)c)
H–C(4’’) —
7.54–7.45 (m)c)
H–C(6’)
H–C(7’) 7.44–7.36 (m)
c) 7.44–7.27 (m)c)
H–C(2’) 7.10 (d, J= 15.4) 7.05 (d, J= 15.4) 7.13 (d, J = 15.4) 7.05 (d, J = 15.4)
CH2(4) 3.49–3.45 (m)c) 3.32–3.29 (m)c) 3.55–3.50 (m)c) 3.44–3.42 (m)c)
CH2(6) 3.32–3.29 (m)c) 3.49–3.45 (m)c) 3.38–3.34 (m)c) 3.55–3.50 (m)c)
CH2(2) 3.21–3.15 (m)c) 3.13–3.08 (m)c) 3.38–3.34 (m)c) 3.29–3.26 (m)c)
CH2(9) 3.13–3.08 (m)c) 3.13–3.08 (m)c)
MeS 2.21, 2.20 (2 s)d) —
CH2(3) 1.74–1.71 (m) 1.68–1.65 (m) 1.87–1.84 (m) 1.79–1.77 (m)
CH2(7) 1.57–1.49 (m)c)
CH2(8)
1.54–1.36 (m)c) 1.38–1.41 (m) 1.48–1.43 (m)
a) 500.1 MHz. b) 600.1 MHz. c) Signals of isomers a/b  overlapped. d) Not
distinguishable.
Moreover, the data also indicate the presence of an acyl-substituted spermidine,
carrying the cinnamoyl and formyl moieties, but not the methylcarbamothioate unit.
Since the sites of attachment of the groups are identical to those found for chisitine 1,
the only difference between 2 and 1 concerns the nature of one substituent. The
additional signals in the aromatic region of the 13C-NMR spectra of 2 at δ 134.7, 134.5
(two singulets, C(2’’)), 131.1 and 131.0 (two doublets, C(5’’)), 128.3 (two overlapping
doublets, C(4’’)), and 127.1 and 127.0 (two doublets, C(3’’)) are assigned to a benzoyl
group [9]. The replacement of the MeSCO in 1 by the PhCO group in 2 is consistent
with the difference of 30 Da in their relative molecular mass. The sites of attachment
of the substituents at the spermidine core for both isomers were established on the
basis of a detailed MS/MS analysis (see the following paragraph) and of the HMBC
spectra (see data in Figure 1). Based on further spectral data, the structure of 2 was
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determined to be N-{3-{[4-(formylamino)butyl][(2E)-3-phenylprop-2-enoyl]amino}-
propyl}benzamide and confirmed by comparison with the analytical data of the
synthetic chisitine 2 (see Synthesis of Chisitine 1 and 2).
Table 2. 13C-NMR Data (125.8 or 150.9 MHz, (D6)DMSO) of Chisitines 1 (1) and 2 (2).
δ in ppm, J in Hz.
1a) 2b)
Isomer 1a Isomer 1b Isomer 2a Isomer 2b
C(1’’) 166.2 (s) 166.0 (s) 166.4 (s) 166.1 (s)
C(1’) 165.2 (s) 164.9 (s) 165.3 (s) 164.9 (s)
CHO 161.0 (d) 160.9 (d) 161.0 (d) 160.9 (d)
C(3’) 141.3 (d) 141.2 (d) 141.3 (d) 141.2 (d)
C(4’) 135.1 (s) 135.0 (s) 135.1(s) 135.0 (s)
C(2’’) — — 134.7 (s) 134.5 (s)
C(5’’) — — 131.1 (d) 131.0 (d)
C(7’) 129.5 (d)c) 129.5 (d) 129.4 (d)
C(6’) 128.7 (d)c) 128.7 (d) 128.6 (d)
C(4’’) — — 128.3 (d)c)
C(5’) 127.9 (d)c) 128.0 (d) 127.8 (d)
C(3’’) — — 127.1 (d) 127.0 (d)
C(2’) 118.4 (d) 118.3 (d) 118.5 (d) 118.4 (d)
C(6) 45.4 (t) 46.8 (t) 45.4 (t) 46.8 (t)
C(4) 44.7 (t) 43.6 (t) 45.0 (t) 43.6 (t)
C(2) 38.1 (t) 38.5 (t) 36.7 (t) 36.9 (t)
C(9) 36.8 (t) 36.6 (t) 36.8 (t) 36.6 (t)
C(3) 29.5 (t) 27.7 (t) 29.6 (t) 27.7 (t)
C(8) 24.9 (t) 26.7 (t) 25.0 (t) 26.7 (t)
C(7) 26.6 (t) 26.3 (t) 26.6 (t) 26.3 (t)
MeS 11.5 (q)c) — —
a) 125.8 MHz. b) 150.9 MHz. c) Signals of isomers a/b overlapped.
Tandem-Mass Spectrometry of Chisitines 1 and 2
A special problem arises in the correct placing of the two substituents (formyl and
(methylthio)carbonyl in case of 1 and formyl and benzoyl in case of 2) at the two
primary N-atoms of the spermidine core. The question that arises is whether the
amino groups are separated by three or four CH2 residues from the third central N-
atom. In addition to our earlier investigations in this field of isomerism [10-12], we
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have studied very carefully this problem. Indeed, it seems necessary to determine the
general characteristic MS fragmentation of this kind of compounds, because similar
natural products isolated in much smaller amounts have to be investigated in the
future.
Compounds 1 and 2 were examined by ESI-MS/MS on a quadrupole ion-trap mass
spectrometer. The two compounds produce two generations of daughter ions (MS2
and MS3) on the basis of which fragmentation mechanisms are proposed. The aim of
their detailed elucidation is to detect characteristic fragmentation pathways that are
diagnostic for the structures proposed for 1 and 2. Characteristic ions could indicate
the location of the substituents as well as the sequence of the polyamine backbone
(PA34 or PA43). The MS/MS data of compound 2 contain more informative ion
responses allowing the postulation of general fragmentation pathways, and are, thus,
discussed first.
Upon MS2, quasi-molecular ion [2 + H]+ at m/z 408 yields the four important
fragment ions a, d, and e/e’ at m/z 390, 278, and 260 (Figure 2a). These ions are
believed to arise from two major Pathways A and B (Scheme 1). Following Pathway A,
[2 + H]+ could lose the cinnamoyl moiety (–130 Da) to form fragment ion d (m/z 278).
This suggested four-center cleavage has already been reported for N -
coumaroylputrescine [12]. Fragment ion d  could lose H2O by reaction of the
secondary amine (N(5)) with either one of the two amide groups to form cyclic
fragment ions e (1,6-cyclization) or e’ (1,7-cyclization), detected at m/z 260 as the base
peaks in MS2. Analogous gas-phase dehydrations involving the amide O-atom have
been observed previously with peptides [13]. The cyclization d →  e  and e’  is
established by investigation of the labeled analog [18O]-2 (Figure 2c). The MS2 of
[[18O]-2 + H]+ (m/z 410) reveals a doublet of peaks corresponding to e at m/z 260 and
[18O]-e’ (m / z 262), which attests that both proposed pathways are followed
concurrently.
Isolation and further fragmentation (MS3) of e and e’ at m/z 260 yield the four new
informative ions g, h, j, and k at m/z 162, 161, 105, and 99 respectively. Probably ion
e’ leads to two cyclic fragment ions g (m/z 162) and k (m/z 99), and to the benzoyl ion
j (m/z 105). These three ions are established to originate from e’ by investigation of
[18O]-2 (see Figure 2c): the corresponding signals for g and j are at m/z 164 (+2 Da) and
107 (+2 Da), respectively, whereas ion k is at the same m/z value 99 (see Scheme 1).
Fragment ion g (m/z 162) reveals that the benzoyl group is linked to the trimethylene
portion of the spermidine, while k (m/z 99) attests that the formyl moiety is located at
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Scheme 1. MS fragmentation of the quasi-molecular ions of chisitine 2 (2).3
                                                 
3 The * denotes the location of the 18O-atom in the case of the labeled analog [18O]-2. The boxes indicate
the selected m/z values submitted to MS2 and MS3. The structures of the fragment ions b, c, f, and i are
not depicted.
Chapter 4 76
the end of the tetramethylene unit. Fragmentation of the six-membered ion e (m/z
260) leads to the formation of ion h recorded at m/z 161, additionally supported by
the MS3 (410 → 260) of ‘pure’ e in the spectrum of [18O]-2 (Figure 2c). The diagnostic
ions g, k, and h, therefore, justify the structure of chisitine 2 (2) independently of the
NMR spectra.
The second important fragmentation Pathway B starts with the direct dehydration of
quasi-molecular ion [2 + H]+ giving rise to a signal at m/z 390 ([2 + H – 18]+). Again,
the loss of H2O is explained by the formation of a cyclic structure, fragment ion a (see
Scheme 1). The fragment ions b (m/z 380), c (m/z 286), f (m/z 189), and i (m/z 134)
(Figure 2a) are not discussed because they are not characteristic for the structure
elucidation of 2.
To support the proposed mechanism, an H/D-exchange experiment was performed.
Thus, 2 was dissolved in an acidic solution of MeOD (0.1% of DCl), and the resulting
deuterated compound [(D2)-2  + D]+ (m/z 411) was investigated by ESI-MS and
MS/MS (Figure 2b). The mass shifts observed of the fragment ions, which depend on
the number of their exchangeable protons, support the proposed mechanism in
Scheme 1. All fragment ions are summarized in Table 3.
In the case of chisitine 1 (1), the presence of the (methylthio)carbonyl substituent
instead of the benzoyl group of 2 has dramatic consequences on the MS behavior of 1
(Figure 3). The S-containing group dominates the fragmentation paths (Scheme 2),
which results in less information to be extracted from the MS/MS data as compared
to those obtained with chisitine 2 (2). Pathway A, which begins with the cleavage of
the cinnamoyl group (–130 Da) and is followed by a dehydration reaction (–18 Da) to
form the two isomeric cyclic fragment ions n and n’ at m/z 230 (in analogy to the ions
e and e’ in the case of 2), is clearly unfavored (Figure 3 and Scheme 2). Despite the low
intensity of the ions obtained, Pathway A is taking place and is attested by the
formation of fragment ions p (m/z 182) when n and n’ are submitted to an MS3
experiment (spectra not shown).
Quasi-molecular ion [1 + H]+ (m/z 378) does not undergo dehydration (Pathway B) but
loses MeSH (–48 Da), following the favored Pathway C, to form the intense fragment
ion l at m/z 330 (base peak in MS2) (Scheme 2). The observation can be rationalized by
the fact that MeSH is a better leaving group than H2O.
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Figure 3. MSn plots of the quasi-molecular ions of chisitine 1 (1): a) MS2 (378) (black line)
and MS3 (378→330) (grey line) of [1 + H]+, and b) MS2 (381) (black line) and
 MS3 (381→332) (grey line) of [(D2)-1 + D]+. Fragment ions are designate
 according to decreasing m/z value (l to r).
Isolation and further fragmentation of ion l (m/z  330) leads to the loss of the
cinnamoyl moiety (–130 Da) under formation of fragment ion o (m/z 200). Subsequent
dehydration gives bicyclic ion p, recorded at m/z 182 (base peak in MS3). The latter
ion can also derive from ion n’ (m/z 230) by expulsion of MeSH (–48 Da). In addition,
fragment ion l (m/z 330) produces the cinnamoyl cation r (m/z 131). Analogously to
the above mentioned H/D-exchange experiment, compound 1 was treated in the
same way to give deuterated analog [(D2)-1 + D]+ (m/z 381). The ion was investigated
by ESI-MS and MS/MS (Figure 3b) to support the mechanism proposed in Scheme 2.
This detailed MS analysis confirmed that the structures of both alkaloids 1 and 2 are
correctly assigned. Nevertheless, it seemed important to ensure them by synthesis
and also to study their NMR spectra in detail.
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Scheme 2. MS fragmentation of the quasi-molecular ions of chisitine 1 (1).
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Synthesis of Chisitines 1 and 2
The two target compounds 1 and 2 were prepared starting from commercially
available mono-Boc-protected butane-1,4-diamine 3 , which was benzylated by
reductive amination of benzaldehyde to give the intermediate 4 (Scheme 3).
Alkylation of 4  with N-(3-bromopropyl)phthalimide afforded 5, which was
debenzylated to the bis-protected spermidine derivative 6 by hydrogenolysis.
Subsequent derivatization of the secondary-amine with cinnamoyl chloride (= (2E)-3-
phenylprop-2-enoyl chloride) yielded compound 7.
N
H
NHBocR
3 R = H
4 R = Bn
N
NHBoc
PhthN
R
5 R = Bn
6 R = H
N
H
N
PhthN
O
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7
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N
H
N
N
H
O
H
O
18O
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[18O]-2
a) 1. PhCHO, MeOH, r.t., 1 h; 2. NaBH4, 19 h; 95%. b) Br(CH2)3NPhth, K2CO3, 70°, 23 h; 78%.
c ) H2 (4 bar), Pd/C, EtOH, r.t., 19 h; quant. d ) (E )-C6H5CH=CHCOCl, Et3N, N,N-
dimethylaminopyridin-4-amine (DMAP), CH2Cl2, r.t., 6 h; 55%. e) CF3COOH, CH2Cl2, r.t., 3 h;
quant. f) HCO2(4-NO2C6H4), Et3N, THF, r.t., 1 h; 82%. g) N2H4·H2O, EtOH, reflux, 2 h; 60%. h)
MeSCOCl or PhCOCl, pyridine, CH2Cl2, r.t., 1 h; 67% (1) or 64% (2). i) 1. PhC[18O2]H, (COCl)2,
DMF, CH2Cl2, r.t., 2 h; 2. 10, Et3N, CH2Cl2, r.t., 2 h; 78%.
Scheme 3. Synthetic route to chisitine 1 (1) and 2 (2) and labeled analog [18O]-2.
The Boc protecting group was removed by the action of CF3COOH, and compound 8
was obtained as the CF3COOH salt. Formylation of 8  by treatment with 4-
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nitrophenyl formate gave the spermidine derivative 9, carrying two of the desired
three N-substituents. Introduction of the last substituent was achieved after the
phthalimide-protecting group was removed by the addition of hydrazine. The
resulting primary amine 10 was treated with S-methyl carbonochloridothioade to
provide the desired alkaloid 1 in 16% overall yield. The reaction of 10 with benzoyl
chloride gave compound 2 in 13% overall yield. All analytical data (HPLC-MS,
MS/MS, 1H- and 13C-NMR, as well as UV spectra) measured for the two synthetic
references were identical with those of the corresponding natural alkaloids 1 and 2.
To study the fragmentation pathway during MS/MS analysis, labeled [18O]-2 was
synthesized analogously by coupling 10 with 18O-labeled benzoyl chloride, which
was prepared according to a reported procedure [14].
Conclusion
Two novel spermidine-derived triamide alkaloids were isolated from the leaves of C.
weinlandii, chisitine 1 (1) and chisitine 2 (2). The structures of the two compounds
were established on the basis of MS and NMR analysis and further confirmed by
comparison with their synthetic references. It was shown that 1 and 2 are both
present as a 1:1 mixture of two isomers when their NMR spectra are recorded at
300 K. The sites of attachment of the substituents were securely established by the
HMBC experiment.
During the mechanistic investigation of the MS fragmentation pathways of the two
compounds by ESI-MS/MS, it was observed that acyl-substituted spermidine
derivatives undergo dehydration by ring-closure reaction. Another distinction comes
from the dependence of the whole dissociation pathways on the lability of the
substituents. The replacement of PhCO by a MeSCO moiety, which possesses the
good leaving group MeSH, affects the MS/MS fingerprint. The MS/MS fragment
ions recorded for the two related compounds arise from alternative pathways.
Attempts to elucidate their structure solely on the basis of MS/MS data are,
therefore, risky.
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Experimental Part
1. General. All chemicals were of reagent grade and purchased from Fluka Chemie AG
or Merck AG. All solvents were of analytical grade quality and were used without
further purification unless otherwise stated. THF was dried over Na/benzophenone.
Hydrogenation: Parr-Instruments Company Inc. Flash chromatography (FC): silica gel
Merck 60 (40-63 µm, 230-400 mesh). TLC: Merck precoated silica-gel-60-F254 plates;
detection by UV at 254 nm, or by spraying Schlittler reagent (H2PtCl6/HCl/KI) or
ninhydrine reagent and heating at 300° for 1 min. IR Spectra: Perkin-Elmer 297; in
cm–1. NMR spectra: Bruker ARX-300 (at 300.13 (1H) and 75.47 MHz (13C)) at 300 K for
all 1D 1H, 13C, DEPT-135, and DEPT-90 experiments; DRX-600 (at 600.13 (1H) and
150.90 MHz (13C)) or DRX-500 (at 500.13 (1H) and 125.76 MHz (13C)) at 300 K for the
1H, 13C,1H-HSQC, 13C,1H-HMBC, 13C,1H-HSQC-TOCSY experiments of 1 and 2;
chemical shifts δ in ppm, referenced against residual non-deuterated solvent; J values
in Hz. HPLC-UV(DAD)-MS: Hewlett-Packard 1100 HPLC system with DAD detector
(Hewlett-Packard Co., Palo Alto, CA, U.S.A.) equipped with a HTS-PAL autosampler
(CTC Analytics, Zwingen, Switzerland), connected to a Bruker ESQUIRE-LC
quadrupole ion-trap instrument (Bruker Daltonik GmbH, Bremen, Germany) equipped
with a combined Hewlett-Packard atmospheric-pressure ion (API) source (Hewlett-
Packard Co., Palo Alto, CA, U.S.A.). Direct-infusion ESI-MS and ESI-MSn experiments
were performed with a syringe infusion pump (Cole-Parmer 74900-05, Cole-Parmer
Instrument Company, Vernon Hills, IL, U.S.A.).
2. Isolation of chisitine 1 (1) and 2 (2). The leaves of Chisocheton weinlandii HARMS were
harvested in 1993 in the garden of the Herbarium Bogoriense, Java, Indonesia, and
voucher specimens have been deposited at the Herbarium of the Faculty of
Pharmaceutical Sciences, Setsunan University.
The crushed leaves (60.0 g) were extracted with MeOH (4 × 1000 ml), and the solvent
was distilled. The MeOH extract (10.9 g) was then suspended in H2O (300 ml) and
the aqueous suspension was extracted with AcOEt (4 × 150 ml). After removal of the
solvent, the extract (3.7 g) was chromatographed (silica gel, CHCl3/MeOH gradient
of increasing MeOH content). Fractions containing 1  and 2  (eluted with
CHCl3/MeOH 5:1), were further purified by semi-preparative HPLC to afford pure
chisitine 1 (1; 26.0 mg) and chisitine 2 (2; 15.3 mg). For the analytical data of 1 and 2,
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which are identical in all respects to those of the synthetic references, see Section 4
below.
3. HPLC-ESI-MS and ESI-MS Investigation. Solvents and reagents: MeCN, MeOH
(HPLC grade; Scharlau, Barcelona, Spain); CF3COOH purum  (Fluka, Buchs,
Switzerland). H2O was purified with a Milli-QRG apparatus (Millipore, Milford, MA,
U.S.A). Samples preparation: 0.2 mg of solid material (natural or synthetic) was
dissolved in 800 µl of MeOH. For the HPLC-ESI-MS experiments, 10 µl of the stock
solutions were injected for the individual runs; for ESI-MS experiments, the solutions
were continuously introduced through the electrospray interface at a flow rate of 6 µl
min–1. For H/D-exchange experiments, 0.2 mg of solid material was dissolved in 500
µl of a 0.1% solution of DCl in MeOD (Merck, Darmstadt, Germany) and stirred at 23°
for 15 min prior to use. Column and chromatographic conditions: Interchrom-
Uptisphere-C18-HDO column (UP3HDO#20QS, 3 µm, 2.1 ×  200 mm; Interchim,
Montluçon, France); flow rate 0.2 ml min–1; mobile phase: gradient within 30 min
from 20 to 50% of solvent B and finally within 5 min from 50 to 100% of B (solvent A
= 0.1% solution of CF3COOH in H2O, solvent B = 0.1% solution of CF3COOH in
MeCN). The UV(DAD) detector was scanning between λ 190 and 400 nm (2 nm step)
at a peakwidth of >0.1 min. The MS conditions: nebulizer gas (N2) 40 psi, dry gas
(N2) 8.5 l min–1, dry temperature 300°, capillary voltage 4200 V, end plate –500 V,
capillary exit 86 V, and skimmer 1 18 V; data acquisitions at normal resolution (0.6
Da at half peak height), under ion charge control (ICC) conditions (10 000) in the
mass range from m/z 50 to 600 and an m/z 39.3 trap drive value. To get representative
mass spectra, 8 scans were averaged for each spectrum.
4. Synthesis of chisitine 1 (1) and 2 (2). tert-Butyl [4-(Benzylamino)butyl]carbamate (4). To
a solution of tert-butyl (4-aminobutyl)carbamate (3; 1.40 g, 7.42 mmol) in MeOH (40
ml), benzaldehyde (0.79 g, 7.43 mmol) was added and the mixture stirred at 23° for
45 min. It was cooled to 0° (ice/water), NaBH4 (0.32 g, 8.46 mmol) was added
portionwise over 1 h, and the solution allowed to warm to 23° and stirred for an
additional 17 h. After evaporation, the residue was dissolved in H2O (50 ml) and
extracted with CH2Cl2 (3 ×  50 ml) and the organic phase dried (MgSO4) and
evaporated: 4 (1.96 g, 95%). Colorless oil. Rf (CH2Cl2/MeOH/25% NH4OH 9:9:1):
0.64. IR (film): 3340s, 2960s, 2920s, 2850s, 2810s, 1950w, 1875w, 1810w, 1700s, 1610m,
1520s, 1455s, 1390s, 1370s, 1275s, 1250s, 1170s, 1030s, 920m, 870m, 780m, 740s, 700s. 1H-
NMR (CDCl3): 7.31–7.17 (m, 5 H); 4.83 (br. s, 1 H); 3.73 (s, 2 H); 3.08–3.06 (m, 2 H);
2.62–2.57 (m, 2 H); 1.50–1.46 (m, 4 H); 1.39 (s, 9 H). 13C-NMR (CDCl3): 156.1 (s); 140.6
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(s); 128.5 (d); 128.3 (d); 127.1 (d); 79.1 (s); 54.2 (t); 49.1 (t); 40.6 (t); 28.6 (q); 28.0 (t); 27.6
(t). ESI-MS (MeOH): 279.2 ([M + H]+).
t e r t - B u t y l  {4-{Benzyl[3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)propyl]amino}butyl}car-
bamate (5). K2CO3 (0.52 g, 3.78 mmol) was added to a solution of 4 (0.96 g, 3.43 mmol)
in MeCN (15 ml) followed by N-(3-bromopropyl)phthalimide (1.01 g, 3.78 mmol),
and the heterogeneous mixture was stirred at 70° for 23 h. The solution was poured
on H2O (50 ml) and extracted with CH2Cl2 (3 × 50 ml), the combined organic phase
dried (MgSO4) and evaporated, and the crude mixture purified by FC
(hexane/AcOEt 3:2 →  1:1): pure 5  (1.80 g, 78%). Slightly yellow oil. R f
(CH2Cl2/MeOH 1:1): 0.58.  IR (film): 3360s, 2990s, 2900s, 2830s, 2780s, 1940w, 1755s,
1690s, 1600s, 1500s, 1435s, 1380s, 1230s, 1155s, 1020s, 900s, 870s, 855s, 705s, 685s, 655s.
1H-NMR (CDCl3): 7.84–7.81 (m, 2 H); 7.71–7.68 (m, 2 H); 7.31–7.17 (m, 5 H); 4.74 (br. s,
1 H); 3.69 (t, J = 7.6, 2 H); 3.52 (s, 2 H); 3.07–3.06 (m, 2 H); 2.50–2.40 (m, 4 H); 1.83
(quint., J = 7.3, 2 H); 1.50–1.45 (m, 4 H); 1.43 (s, 9 H). 13C-NMR (CDCl3): 168.5 (s); 156.2
(s); 139.8 (s); 134.0 (d); 132.4 (s); 129.1 (d); 128.3 (d); 127.0 (d); 123.3 (d); 79.1 (s); 58.8 (t);
53.6 (t); 51.4 (t); 40.7 (t); 36.6 (t); 28.6 (q); 28.0 (t); 26.3 (t); 24.7 (t). ESI-MS (MeOH +
NaI): 488.3 ([M + Na]+).
t e r t - B u t y l  {4-{[3-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)propyl]amino}butyl}carbamate
(6). A mixture of 5 (1.18 g, 2.54 mmol) and Pd/C (200 mg) in EtOH (100 ml) was
stirred for 19 h at 23° under a H2 pressure of 4 bar [15]. The catalyst was filtered off
via Celite® and washed with MeOH (150 ml). The combined filtrate was evaporated: 6
(1.26 g, quant.). Colorless solid. Rf (CH2Cl2/MeOH 1:1): 0.61. IR (film): 3370m, 2940m,
2790m, 2440w, 2780s, 1770w, 1705s, 1690s, 1600w, 1530m, 1465m, 1440m, 1400m, 1365m,
1270m, 1250m, 1175m, 715m. 1H-NMR (CDCl3): 7.84–7.81 (m, 2 H); 7.72–7.69 (m, 2 H);
5.14 (br. s, 1 H); 3.85 (t, J = 6.5, 2 H); 3.17–3.11 (m, 2 H); 3.04–2.95 (m, 4 H); 2.32–2.27
(m, 2 H); 1.95–1.85 (m, 2 H); 1.66–1.47 (m, 2 H); 1.41 (s, 9 H). 13C-NMR (CDCl3): 168.6
(s); 156.5 (s); 134.3 (d); 132.1 (s); 123.6 (d); 79.5 (s); 47.8 (t); 45.8 (t); 39.9 (t); 35.2 (t); 28.6
(q); 27.3 (t); 25.8 (t); 23.3 (t). ESI-MS (MeOH): 320.2 (5), 376.3 (100, [M + H]+), 398.2 (6,
[M + Na]+).
t e r t - B u t y l  {4-{[3-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)propyl][(2E)-3-phenylprop-2-
enoyl]amino}butyl}carbamate (7). According to [16], Et3N (3.67 g, 36.29 mmol) and
DMAP (42 mg, 0.34 mmol) were added to a solution of 6 (948 mg, 2.54 mmol) in
CH2Cl2 (25 ml). After stirring at 23° for 30 min, (2E)-3-phenylprop-2-enoyl chloride
(847 mg, 5.08 mmol) was added, and the mixture was stirred at 23° for an additional
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6 h. The solution was washed with saturated aqueous NH4Cl solution (3 × 30 ml)
followed by saturated aqueous Na2CO3 solution (3 × 30 ml). The organic layer was
dried (MgSO4) and evaporated. The crude mixture was purified by FC
(hexane/AcOEt 1:1 → 2:3): pure 7 (707 mg, 55%). Yellow oil. Rf (hexane/AcOEt 1:1):
0.11.  IR (film): 3350m, 3070m, 2980s, 2940s, 2870m, 1775s, 1710s, 1655s, 1610s, 1525s,
1475s, 1460s, 1445s, 1405s, 1375s, 1340s, 1280s, 1260s, 1180s, 1150m, 1100m, 1080m,
1045m, 985m, 900m, 865m, 775s, 730s, 695m, 675m. 1H-NMR (CDCl3): 7.88–7.82 (m, 2
H); 7.74–7.63 (m, 3 H); 7.52–7.43 (2 m, 2 H); 7.36–7.31 (m, 3 H); 6.83, 6.76 (2 d, J = 15.4
each, ratio 1:1, 1 H); 4.65 (br. s, 1 H); 3.77–3.72 (m, 2 H); 3.55–3.44 (m, 4 H); 3.18–3.12
(m, 2 H); 2.10–1.95 (m, 2 H); 1.75–1.62 (m, 2 H); 1.57–1.47 (m, 2 H); 1.41 (s, 9 H). 13C-
NMR (CDCl3): 168.4 (s); 166.5, 166.4 (2 s); 156.2 (s); 143.0 (d); 135.5 (s); 134.3, 134.1 (2
d); 132.3, 132.1 (2 s); 129.7, 128.9, 128.0 (3 d); 123.6, 123.4 (2 d); 117.5, 117.3 (2 d); 79.4
(s); 48.0, 46.6, 46.1, 44.6 (4 t); 40.2 (t); 36.2, 35.7 (2 t); 29.0 (t); 28.6 (q); 27.8, 27.6, 27.4,
27.2, 25.4 (5 t). ESI-MS (MeOH + NaI): 528.3 ([M + Na]+).
4-{[3-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)propyl][(2E)-3-phenylprop-2-enoyl]amino}-
butan-1-ammonium Trifluoroacetate (8). CF3COOH (1.58 g, 13.85 mmol) was added
dropwise to a solution of 7 (700 mg, 1.39 mmol) in CH2Cl2 (10 ml), and the mixture
was stirred at 23° for 3 h. Evaporation gave 8 (929 mg, quant.). Brownish oil. Rf
(CH2Cl2/MeOH 1:1): 0.50. IR (film): 3310m, 1805s, 1745s, 1680s, 1615m, 1535m, 1505m,
1475m, 1440s, 1420m, 1370m, 1340m, 1240s, 1205s, 1110m, 1065m, 1010m, 850m, 830m,
805m, 760s, 745m. 1H-NMR (CDCl3): 7.74–7.62 (m, 4 H); 7.47 (d, J = 15.4, 1 H); 7.35–7.18
(m, 5 H); 6.64 (d, J = 15.4, 1 H); 3.68–3.58 (m, 2 H); 3.47–3.41 (m, 4 H); 3.12–3.10 (m, 2
H); 2.03–1.94, 1.92–1.87 (2 m, ratio 3:1, 2 H); 1.72–1.65 (m, 4 H). 13C-NMR (CDCl3):
169.5, 169.3 (2 s); 168.9 (s); 160.7 (q, J(CO,F) = 41.2); 146.0 (d); 134.8, 134.7 (2 d); 134.2
(s); 131.7 (2 s); 130.9, 129.2, 128.3 (3 d); 123.8, 123.7 (2 d; 115.2 (q, J(C,F) = 286.9); 115.3,
115.2 (2 d); 48.6, 47.0, 46.5, 45.8 (4 t); 40.5, 40.2 (2 t); 35.9, 35.5 (2 t); 28.3, 27.4, 26.4, 24.7,
24.4, 24.0 (6 t). ESI-MS (MeOH): 406.3 (100, [M + H]+), 428.2 (6, [M + Na]+).
(2E)-N-[3-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)propyl]-N-[4-(formylamino)butyl]-3-
phenylprop-2-enamide (9). According to [17], 4-nitrophenyl formate (231 mg, 1.38
mmol) in THF (4 ml) was added dropwise to a solution of 8 (700 mg, 1.35 mmol) and
Et3N (684 mg, 6.76 mmol) in THF (10 ml). The mixture was stirred at 23° for 1 h.
Evaporation and purification of the crude product by FC (CH2Cl2/MeOH 93:7 → 9:1)
gave pure 9 (481 mg, 82%). Yellowish oil. Rf (CH2Cl2/MeOH 9:1): 0.39.  IR (film):
3370m, 3140m, 3020m, 2950m, 1810s, 1750s, 1715s, 1690s, 1640s, 1575m, 1540m, 1475s,
1440s, 1420s, 1370m, 1345m, 1230m, 1175m, 1115m, 1070m, 1020m, 930m, 805s, 760s. 1H-
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NMR (CDCl3): 8.16 (br. s, 1 H); 7.86–7.81 (m, 2 H); 7.74–7.62 (m, 3 H); 7.51–7.31 (m, 5
H); 6.81, 6.76 (2 d, J = 15.4 each, ratio 1:1, 1 H); 6.40, 6.01 (2 br. s, 1 H); 3.78–3.71 (m, 2
H); 3.55–3.43 (m, 4 H); 3.38–3.23 (m, 2 H); 2.10–1.92 (m, 2 H); 1.68–1.52 (m, 4 H). 13C-
NMR (CDCl3): 168.4 (s); 166.6 (s); 164.7, 161.5 (2 d); 143.3, 143.1 (2 d); 135.4, 135.3 (2 s);
134.4, 134.3 (2 d); 132.2, 132.1 (2 s); 129.8, 129.0, 128.0, 123.6, 123.4 (5 d); 117.4, 117.1 (2
d); 48.1, 46.4, 46.3, 44.8 (4 t); 37.7 (t); 36.2, 35.7 (2 t); 29.0, 27.3, 27.2, 26.3, 25.5 (5 t). ESI-
MS (MeOH + NaI): 456.3 ([M + Na]+).
(2E)-N-(3-Aminopropyl)-N-[4-(formylamino)butyl]-3-phenylprop-2-enamide  (10) .
According to [16], N2H4·H2O (412 mg, 8.23 mmol) was added to a solution of 9 (360
mg, 0.83 mmol) in EtOH (10 ml) and the mixture was stirred under reflux for 2 h.
After cooling, the solvent was evaporated, the residue treated with 2N aqueous HCl
solution (10 ml), the mixture filtered, and the filtrate basified with saturated aqueous
Na2CO3 solution (15 ml). The aqueous layer was extracted with CH2Cl2 (3 × 20 ml)
and the combined organic layers were dried (MgSO4) and evaporated: 10 (152 mg,
60%). Yellowish oil. Rf (CH2Cl2/MeOH 1:1): 0.05. IR (film): 3360m, 3130m, 3010m,
2940m, 1710s, 1685s, 1635s, 1535m, 1495s, 1465s, 1420m, 1365m, 1340m, 1320m, 1270m,
1240m, 1220m, 1020m, 805m, 750m, 725m . 1H-NMR (CDCl3): 8.14 (s, 1 H); 7.67–7.66,
7.62–7.60, 7.57–7.56 (3 m, ratio 43:50:7, 1 H); 7.51–7.42, 7.34–7.28 (2 m, 5 H); 6.96, 6.79,
6.41 (3 d, J ≈ 15.4 each, 1 H); 6.77, 6.54 (2 br. s, 1 H); 3.51–3.39 (m, 4 H); 3.34–3.21 (m, 2
H); 2.76–2.58 (m, 2 H); 1.74–1.50 (m, 8 H). 13C-NMR (CDCl3): 166.8, 166.7 (2 s); 164.8,
161.6 (2 d); 142.9, 142.7 (2 d); 135.4, 135.3 (2 s); 129.7, 128.9, 128.0 (3 d); 117.9, 117.4 (2
d); 47.6, 46.2, 45.8, 43.9, 39.3, 39.1, 37.7, 37.5 (8 t); 33.2, 31.4 (2 t); 27.1, 26.9, 26.4, 25.4 (4
t). ESI-MS (MeOH + HCOOH): 286.2 (6), 304.2 (100, [M + H]+), 326.2 (6, [M + Na]+).
 S-Methyl{3-{[4-(Formylamino)butyl][(2E)-3-phenylprop-2-enoyl]amino}propyl}carbamo-
thioate (= chisitine 1; 1). In analogy to [18], S-methyl carbonochloridothioate (43 mg,
0.39 mmol) was added dropwise to a solution of 10 (107 mg, 0.35 mmol) and pyridine
(31 mg, 0.39 mmol) in CH2Cl2 (3 ml) and the mixture was stirred at 23° for 1 h.
Evaporation and purification of the crude mixture by FC (CH2Cl2/MeOH 95:5 → 9:1)
gave pure 1 (90 mg, 67%). Yellowish oil that solidified upon standing at 4°. M.p.
89–90°. Rf (CH2Cl2/MeOH 9:1): 0.31. IR (film): 3350s, 3120m, 3000m, 2940m, 1705s,
1685s, 1635s, 1570s, 1535s, 1520s, 1495s, 1470s, 1420s, 1365m, 1340m, 1255s, 1160m,
1015m, 800m, 745m, 725m. NMR: Tables 1 and 2. ESI-MS (MeOH): 378.2 (26, [M + H]+),
400.3 (88, [M + Na]+), 416.1 (100, [M + K]+). MSn: Table 3. HPLC-UV-MS: tR = 23.8 min;
λmax 204, 218, 282 nm.
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N-{3-{[4-(Formylamino)butyl][(2E)-3-phenylprop-2-enoyl]amino}propyl}benzamide (=
chisitine 2; 2). According to [19], benzoyl chloride (18 mg, 0.13 mmol) was added
dropwise to a solution of 10 (36 mg, 0.12 mmol) and pyridine (10 mg, 0.13 mmol) in
CH2Cl2 (2 ml) and the mixture was stirred at 23° for 2 h. Evaporation and purification
of the crude mixture by FC (CH2Cl2/MeOH 95:5 → 9:1) gave pure 2 (31 mg, 64%).
Yellow oil that solidified upon standing at 4°. M.p. 102–103°. Rf (CH2Cl2/MeOH 9:1):
0.25. IR (film): 3290s, 3050m, 2920s, 2860m, 2230w, 1645s, 1595s, 1535s, 1485s, 1455s,
1430s, 1380s, 1325s, 1300s, 1240m, 1190s, 1120m, 1090m, 1070m, 1025m, 975m, 910m,
855m, 800m, 765s, 700s. NMR: Tables 1 and 2. ESI-MS (MeOH): 408.3 (63, [M + H]+),
430.2 (100, [M + Na]+), 446.1 (70, [M + K]+). MSn: Table 3. HPLC-UV-MS: tR = 25.0 min;
λmax 220, 280 nm.
N-{3-{[4-(Formylamino)butyl][(2E)-3-phenylprop-2-enoyl]amino}propyl}benz[18O]amide
([18O]-2). (COCl)2 (9 mg, 0.07 mmol) was added to a cold (ice/water) solution of
[18O2]benzoic acid (8 mg, 0.07 mmol; prepared according to [14]) and DMF (ca. 0.5 ml,
catalyst) in CH2Cl2 (1.5 ml), and the resultant mixture allowed to warm to 23° and
stirred for an additional 2 h. After evaporation of the oil, the residue was dissolved in
CH2Cl2 (1 ml) and the mixture cooled to 0° (ice/water) and treated with a solution of
10 (10 mg, 0.03 mmol) and Et3N (7 mg, 0.07 mmol) in CH2Cl2 (1.5 ml). After stirring at
23° for 2 h, the solvent was evaporated and the crude mixture was purified by
preparative TLC (CH2Cl2/MeOH 9:1): [18O]-2 (11 mg, 78%). Rf (CH2Cl2/MeOH 9:1):
0.25. ESI-MS (MeOH + NaI): 432.3 ([M + Na]+). MSn: Table 3.
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